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THE EFFECTS OF SLEEP RESTRICTION ON BIOLOGICAL,
PSYCHOLOGICAL, AND NEUROCOGNITIVE MEASURES OF HEALTH

by

Margaret S. Lorenzetti

Nova Southeastern University

ABSTRACT

Chronic sleep restriction impacts a significant proportion of the population, even though
health is optimized following a minimum of seven hours of sleep. A preponderance of the
literature examining the effects of sleep loss focuses on males and total sleep deprivation.
Sleep restriction paradigms provide more ecological validity, as they are more consistent
with sleep loss characterized in epidemiological studies. Moreover, enhancing the
understanding of sleep loss among women, who are generally the gender most likely to
encounter negative health as a result of poor sleep quality, is crucial. Thus, this
investigation aimed to examine sleep restriction amongst a female sample. Group
assignment was determined on the basis of objective and subjective measures of sleep
collected in the baseline phase. Participants were then placed in the Naturally Sleep
Restricted (NSR) group (n = 11), or the Experimentally Sleep Restricted (ESR) group (n
= 9). The ESR group was assessed on Day 1 and Day 7 (i.e., prior to and following sleep
restriction).
We hypothesized that following sleep restriction, the ESR group would exhibit
decrements in biological, psychological, and neurocognitive functioning. We further
hypothesized that relative to the ESR group at Day 1, the NSR group would exhibit
reduced functioning. However, we hypothesized that the NSR participants would fare
better compared to the ESR group at Day 7. Results indicated that following sleep
restriction, the ESR group exhibited elevated IL-1β, anxiety, tension, and fatigue and a
decrease in depression, anger, and reaction time. The NSR group evidenced elevated IL-6
relative to the ESR group at Day 1. Finally, relative to the NSR group, the ESR group at
Day 7 exhibited elevated anxiety, tension, fatigue, confusion, and correct non-matches on
a measure of working memory. Further, the ESR group at Day 7 evidenced lower levels
of depression and anger relative to the NSR group. Generally, results indicate that
volitional sleep restriction (NSR) produces a different constellation of outcomes relative
to non-volitional sleep restriction (ESR). Future research should examine these variables
with a larger sample size and over a longer period of sleep restriction in order to assess
further changes in functioning.

ix
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Chapter 1: Statement of the Problem
Chronic sleep restriction appears to be a characteristic feature of modern society
(Stenuit & Kerkhofs, 2008). For instance, the average number of hours slept in 1910 was
estimated at nine hours per night, whereas this number has fallen to an estimated seven
and a half hours per night (Stenuit & Kerkhofs, 2008). Furthermore, it appears as though
this rate of decline (i.e., average number of hours slept per night) has continued to fall
over the last two decades. Specifically, the proportion of the population that now sleeps
less than six hours per night has nearly doubled, with an estimated 20% of individuals
sleeping less than six hours per night in 2009, compared to 12% in 1998 (National Sleep
Foundation, 2009). More recently it is estimated that one-third of the adult American
population sleeps less than seven hours per night (Luyster, Strollo, Zee, & Walsh, 2012).
Given that the Centers for Disease Control ([CDC], 2014)) state that health and wellbeing are optimized when individuals routinely achieve a minimum of seven hours of
sleep per night, it is alarming to see that a large proportion of the population achieves
well below what is recommended, a term the CDC (2014) refers to as short sleep
duration (i.e., sleeping less than seven hours per night within a 24-hour period).
Vgontzas and colleagues (2004) argue that this fall in average sleep time stems from
evolving societal pressures in the form of work, family, and social changes. With respect
to occupational pressures, short sleep duration results from extended work hours, shift
work, and commute times, whereas societal pressures impinge on one’s sleep in the
forms of enhanced reliance on technology (i.e., electricity, electronic devices) (Faraut,
Boudjeltia, Venhamme, & Kerkhofs, 2012; Luyster et al., 2012). Furthermore, a
pervasive, Western attitude that if “you snooze, you lose” (Luyster et al., 2012) conveys
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the message that sleep is secondary to occupational success. In such cases, the enhanced
occupational demands seen in modern society may be tolerated at the expense of reduced
sleep. Finally, it may also be conceivable that a lack of awareness surrounding the
deleterious effects of shortened sleep duration persists in the population. For instance,
Luyster and colleagues (2012) speculate that individuals may view “their sleep as
adequate as long as a minimal level of behavioral functioning can be maintained.” (p.
727). As such, a large number of individuals may chronically operate at a reduced level
of functioning without recognizing that this may in fact be deleterious.
While there is a large degree of agreement in the literature with respect to what
constitutes significant sleep loss, less agreement exists on three other considerations,
which are important in establishing the impact of sleep loss. First, there are
inconsistencies in the literature with respect to the specific paradigm of sleep
manipulation employed and its ensuing consequences. In other words, the literature
draws a distinction between sleep deprivation and sleep restriction, and while both may
constitute short sleep duration as defined by the CDC (2014), they differ vastly not only
in the quantity of how much sleep is shortened, but also in their deleterious effects.
Whereas sleep deprivation refers to the complete absence of sleep for a given amount of
time (e.g., lasting one night or more), sleep restriction refers to a reduction in sleep
quantity compared to the individual’s respective baseline amount of sleep (Reynolds &
Banks, 2010). The most widely adopted and researched paradigm in behavioral sleep
medicine focuses on sleep deprivation (Reynolds & Banks, 2010). Despite this, sleep
restriction is a phenomenon that better approximates the current state of affairs in terms
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of the general populations; meaning, it has a higher degree of external validity when
considering what generalizes to the population at large (Stenuit & Kerkhofs, 2008).
Second, disagreement exists as to whether individuals incur a different spectrum of
deleterious effects depending on whether their restricted sleep is habitual versus imposed
(i.e., in times of stress or periods of time requiring a condensed amount of sleep). In other
words, how is an individual’s functioning differentially impacted depending on whether
they are volitionally sleeping less versus non-volitionally sleeping less? An emerging
trend in sleep research has attempted to address inter-individual differences as they
pertain to sleep needs (Banks & Dinges, 2007), and that depending on one’s biological
propensity, individuals may require different amounts of sleep. Thus, it is possible that
individuals who sleep less than seven hours volitionally, have different homeostatic
processes and genetics subserving the sleep-wake cycle (Goel, Basner, Rao, & Dinges,
2013), relative to individuals that non-volitionally sleep less than seven hours per night.
For instance, Goel and colleagues (2013) found “trait-like individual differences in the
magnitude of fatigue, sleepiness, sleep homeostasis, and cognitive performance
vulnerability to acute total sleep deprivation and to chronic sleep restriction” (p. 9).
Meaning, individual differences in biological rhythms and genetics may bolster one’s
abilities to better negate the effects of short sleep duration. Despite this, it remains
unclear as to whether individuals who are chronically and volitionally sleeping fewer
than seven hours per night are incurring negative health effects, or is the chronic and
habitual nature of their short sleep duration an indicator of their natural biological
propensity? Additionally, if individuals habitually sleeping greater than seven hours per
night are asked to restrict their sleep, are they more likely to encounter the deleterious
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effects of sleep restriction due to its non-volitional nature? While sleep research has long
addressed and manipulated intra-individual differences with respect to sleep, far less
research has addressed the impact that ‘trait-like’ inter-individual differences play.
Third, there exists disagreement as to how, and to what extent women encounter the
deleterious effects of sleep loss. In large part, these uncertainties stem from a lack of
research that has examined sleep loss amongst samples of women (Stenuit & Kerkhoffs,
2008; Suarez, 2008). By virtue of their biological and physiological makeup, women
exhibit “distinct hormonal and physical changes at specific time points, such as puberty,
pregnancy, and menopause” (Mallampalli & Carter, 2014, p. 553), which lead to genderspecific sleep patterns and habits (Suarez, 2008). It is these specific hormonal changes
that complicate the process of studying sleep amongst female samples, and have rendered
them the understudied gender. For instance, in times of hormonal fluctuations, including
puberty, the week prior to menstruation, pregnancy, and menopause, the rate at which
women report sleep problems increases (Mallampalli & Carter, 2014). Yet, it cannot be
assumed that the existing sleep literature that has included female participants has
accounted for, or has controlled for the effects of hormonal fluctuations (e.g., Dinges et
al., 1997; Faraut et al., 2012). Additionally, it cannot be assumed that findings from sleep
research including a strictly male sample can be extrapolated to a female sample. More
specifically, women differ from men with respect to hormonal makeup and fluctuations,
sleep architecture, sleep latency, and in the rate at which they are diagnosed with clinical
sleep disorders (Mallampalli & Carter, 2014). Thus, in order to adequately understand
how women are impacted by poor sleep quality, a female sample in which the effects of
hormonal fluctuations are accounted for is necessary.
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Mounting evidence suggests that, despite the relative lack of sleep research involving
women, they are the gender most likely to encounter negative health effects as a result of
poor sleep quality (Suarez, 2008). From an epidemiological standpoint, women are
diagnosed with insomnia 40% more and are diagnosed with restless legs syndrome twice
as often, compared to men (Mallampalli & Carter, 2014). Furthermore, women under the
age of 55 report more sleepiness compared to men, and they also experience longer sleep
latency (Mallampalli & Carter, 2014). There is a pressing need to empirically document
how the sleep paradigm having the most ecological validity, namely, chronic sleep
restriction, impacts the gender not only incurring the greatest deleterious effects, but also
represents the gender that has seemingly been disproportionately overlooked in the
existing literature. Thus, the current study will attempt to address these issues by
employing a short-term sleep restriction paradigm amongst a sample of young women, by
specifically examining their biological, psychological, and neurocognitive functioning.
Because sleep restriction takes many forms, particularly depending on its chronicity, we
will attempt to uncover whether short-term sleep restriction differentially impacts
women’s functioning depending on whether the sleep restriction is naturally-occurring, or
whether it is imposed in an experimental manner.

6
Chapter 2: Review of the Literature
Sleep restriction has long been thought to be a benign phenomenon, relative to sleep
deprivation (Banks & Dinges, 2007; Dinges et al., 1997; Short & Banks, 2014). This
assumption in part stems from previous literature that failed to incorporate adequate
methodological considerations required in sleep restriction research (Banks & Dinges,
2007), thus leading to the belief that sleep restriction produces little adverse effects (Short
& Banks, 2014). Conceivably, this assumption may also stem from the reported
phenomenon in which sleep restricted individuals underreport and lack insight into the
negative effects they experience as a result of their reduced sleep duration (Banks &
Dinges, 2007; Short & Banks, 2014). Meaning, sleep restricted individuals tend to
underreport and not accurately pinpoint areas of their functioning that may be harmed by
chronic sleep restriction. In addition, sleep restriction has increasingly become a
characteristic feature of modern society (Luyster et al., 2012) and may thus be viewed as
a normalized experience, possibly leading individuals to discount the negative impacts
that their restricted sleep habits may have.
Increasing amounts of research however, are documenting the deleterious effects that
sleep restriction poses for one’s health and wellbeing. For instance, Banks and Dinges
(2007) reported that short-term sleep restriction, as defined by restricting one’s sleep to
four hours per night for a span of six nights, is associated with marked physiological
changes, such as reduced glucose intolerance, elevated blood pressure and inflammatory
markers, increased activation of the sympathetic nervous system and reduced leptin
levels. Furthermore, they also reported a relationship between sleep restriction and
weight gain (and possibly obesity) – a relationship primarily mediated by appetite-
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regulating hormones, such as leptin and ghrelin (Banks & Dinges, 2007). Moreover, sleep
restriction results in elevated markers of inflammation, including IL-6 and TNF-alpha,
having consequences in the form of insulin-resistance, osteoporosis and cardiovascular
disease (Banks & Dinges, 2007). In terms of the psychological consequences, they found
ensuing mood disturbances in the form of sleepiness, confusion, and fatigue, and in terms
of the neurocognitive consequences, detailed a reduction in psychomotor vigilance and
slowed working memory (Banks & Dinges, 2007). Finally, the summation of
physiological, psychological, and neurocognitive deficits resulting from sleep restriction
enhance the risk of motor vehicle accidents and death (Banks & Dinges, 2007).
Luyster and colleagues (2012) echo similar warnings with respect to the deleterious
effects associated with sleep restriction. Broadly speaking, they state that individuals
encounter the greatest risks in the realms of cardiovascular and metabolic functioning and
develop increased vulnerability for developing cancer and/or being involved in a motor
vehicle accident. More specifically, they posit that short sleep duration is associated with
increased risk of cerebrovascular accidents, particularly of an ischemic nature, as well as
myocardial infarction and atherosclerosis. Metabolically, they described an emerging
trend in behavioral sleep medicine to hypothesize an inverse relationship between
habitual number of hours slept and one’s body mass index, obesity, and risk of
developing type 2 diabetes. With respect to the link between short sleep duration and
cancer, Luyster et al., (2012) indicated that individuals routinely having short sleep
durations are at an increased risk of developing breast, colorectal and prostate cancer.
Finally, and similar to Banks and Dinges’ (2007) stance, Luyster and colleagues (2012)
indicated that “sleep deprivation results in impairments in cognitive and motor
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performance that are comparable to those induced by alcohol consumption at or above
the legal limit” (p. 731). While referring to sleep deprivation and not restriction, it stands
to reason that chronically achieving fewer hours of sleep than is needed and experiencing
feelings of sleepiness has implications for one’s cognitive and motor performance as
well. Importantly, it is estimated that approximately 20% of motor vehicle accidents are
attributable to impaired driving as a result of sleepiness (Luyster et al., 2012).
Suarez (2008) went a step further and provided intriguing evidence that many of the
links between short sleep duration and reduced health may be mediated by one’s gender.
In other words, it was found that there are gender-specific associations when it comes to
sleep restriction and ensuing consequences for one’s health. For example, increased sleep
latency, and reduced self-reported sleep quality – measures of poor sleep hygiene, were
associated with elevated psychosocial distress, fasting insulin, fibrinogen and
inflammatory biomarkers, but only amongst the women in the study (Suarez, 2008). The
author reasoned that these findings may be partially explicated by the gender-related
differences that have been observed with a variety of neurochemicals, including
tryptophan, serotonin, and melatonin (Suarez, 2008). More specifically, these
neurochemicals play a role in sleep, sleep onset, as well as biological and psychological
processes including mood regulation, inflammation, thrombogenesis, and eating, and may
exert differential effects when it comes to women’s sleep patterns. Of importance, is the
notion that women differ in their hormonal composition and vulnerability to the negative
effects of sleep restriction, thus adding weight to the importance of partialing out gender
in research paradigms of behavioral sleep medicine.
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Broadly speaking, the negative outcomes that individuals encounter as a result of
sleep restriction have biological, psychological, or neurocognitive consequences. Given
that sleep is a behavior that uniformly takes place across the animal kingdom, that it is
encoded in our genes, and that it is necessary for our survival (Luyster et al., 2012), it
stands to reason that restricted amount of sleep have the potential to produce profound
deficits in one’s health and wellbeing. As indicated, the current study will attempt to
explore the biological, psychological, and neurocognitive consequences of sleep that is
either naturally restricted or experimentally restricted amongst a sample of women.
Biological Consequences
Previous research examining the deleterious effects of sleep restriction and
deprivation on one’s biological functioning have traditionally examined proinflammatory cytokines, such as the interleukins, as well as glucocorticoids, such as
cortisol (Vgontzas et al., 2004). While these have not been uniformly studied, a general
trend suggesting elevations amongst the interleukins (i.e., IL-6, IL-1ß) and cortisol
following poor sleep is apparent. Meaning, various forms of sleep restriction and
deprivation have been associated with either elevations or alterations in daily IL-6, IL-1ß,
and cortisol secretory patterns, which not surprisingly have implications for one’s
endocrine and metabolic health, as well as self-reported psychological health (e.g.,
Omisade, Buxton, & Rusak, 2010).
With respect to the gender gap in sleep research (i.e., disproportionately conducted on
males), it is most apparent when considering the biological factors, as females have
traditionally been excluded as a result of having comparatively complex and fluctuating
hormonal makeups.
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Given that the interleukins and cortisol exhibit diurnal patterns, and that females exhibit
monthly hormonal fluctuations, additional steps must be taken to ensure that these are not
confounded. For instance, LeRoux, Wright, Perrot, and Rusak (2014) specify that one’s
menstrual cycle phase produces altered cortisol responses, having implications for one’s
endocrine and adrenal status following sleep loss. In particular, in their study consisting
of 18 females divided equally into either the follicular or luteal phase of their cycles,
participants spent two nights in the lab, in which they slept 10 hours the first night and
restricted their sleep to three hours the second night. Results indicated that following the
night of sleep restriction, “Women in the follicular phase showed a significant decrease in
their cortisol awakening responses…and a sustained elevation in afternoon/evening
cortisol levels, as has been reported for men. Women in the luteal phase showed neither a
depressed CAR, nor an increase in afternoon/evening cortisol levels.” (p.34). Thus,
women in the follicular phase did not exhibit a comparable decrease in their cortisol
levels in the afternoon following sleep restriction, having significant implications for
endocrine readings and interpretations. Conversely, women in the luteal phase did exhibit
sustained elevations in cortisol throughout the afternoon. Taken together, these results
demonstrate the intricate interplay between menstrual cycle phase, sleep, and endocrine
status, highlighting the importance of implementing the necessary parameters to account
for these fluctuations.
As a result of the reduced female inclusion in this line of study, uncertainties
surrounding whether, and to what extent, their biological functioning is impacted
following sleep restriction is unclear. For instance, Vgontzas et al., (2004) state that,
compared to males, females are more resilient to the effects of sleep loss (in terms of
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their post sleep-restriction IL-6), whereas others (i.e., Irwin, Carillo, & Olmstead, 2010;
Suarez, 2008; Tartar et al., 2015) note that women are more impacted by sleep restriction,
as they evidence a heightened psychological and physiological toll. Evidently, additional
research is needed as a means for understanding how women’s biological functioning is
impacted following sleep restriction. The current body of literature either fails to account
for females’ hormonal fluctuations, comprises groups composed of both males and
females, or simply excludes females from the study altogether. Thus, the current review
of the literature will cite studies comprising both genders, and when possible, results
specific to females will be highlighted.
Cortisol. With respect to cortisol, Banks and Dinges (2007) indicate that sleep
restriction, which comprised of sleeping approximately four hours per night for 10 nights,
resulted in elevations in cortisol, having negative outcomes in the form of increased
sympathetic activation, diminished thyrotropin activity, and decreased glucose tolerance.
Omisade and colleagues (2010) add that acute sleep loss is associated with sustained
elevations of cortisol in the evening, and this has been tied to diminished leptin (an
appetite-suppressing hormone), increased ghrelin (an appetite-stimulating hormone), as
well as increases in self-reported hunger and a particular preference for foods high in
calories and/or carbohydrates. Importantly, in the absence of disrupted sleep, cortisol
follows a diurnal pattern, such that it is at its zenith in the morning, and at its nadir in the
evening (Pledge, Grosset, & Onambélé-Pearson, 2011). Whereas some studies (e.g.,
Vgontzas et al., 2004) have found that sleep restriction results in an altered pattern of
cortisol secretion, others (e.g., Omisade et al., 2010), have found evidence for both
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elevations of mean cortisol levels throughout the day, as well as altered secretory
patterns.
Vgontzas and colleagues (2004) examined how participants’ (12 men and 13 women)
cortisol was impacted following 8 days of sleep restriction. More specifically, following a
4-day baseline period, wherein participants were asked to sleep 8-hours per night,
participants were then asked to restrict their sleep to 6-hours per night. Results indicated
that sleep restriction did not impact mean amounts of cortisol secretion, but results did
suggest that, compared to their baseline, men exhibited reduced peak levels of cortisol in
the morning, compared to women, and the authors speculated that this may be evidence
that women are more resilient to the effects of sleep restriction. Similarly, cortisol
patterns were observed in both men (n = 5) and women (n = 6) following 14 days of
either 8.5 or 5.5 hours of time in bed (Nedeltcheva, Kessler, Imperial, & Penev, 2009).
Results did not suggest differences between the 8.5 and 5.5 hour group with respect to
peak, trough, daytime, and nighttime cortisol concentrations. Information regarding
gender differences was not provided.
In contrast, Kumari, Badrick, Ferrie, Perski, Marmot, and Chandola (2009) found that
short sleep duration, as defined by sleeping less than five hours per night, is associated
with an altered diurnal pattern amongst both males and females (N = 2751), such that
cortisol patterns become flattened. Participants provided six saliva samples over the
course of the day, the first upon waking, the second 30 minutes afterwards, the third two
and a half hours afterwards, the fourth eight hours afterwards, the fifth twelve hours
afterwards, and the sixth at bedtime (Kumari et al., 2009). Results indicated that number
of hours slept the previous night is correlated with higher cortisol on awakening, whereas
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participants having slept five hours or less exhibited the lowest cortisol in the morning.
However, this group exhibited the steepest morning rise in cortisol; thus, sleeping more
hours is associated with a less steep rise in morning cortisol (Kumari et al., 2009).
Interestingly, this effect remained even after controlling for potential confounders such as
age, sex, and awakening time (Kumari et al., 2009).
In an attempt to address the lack of well-controlled studies examining females’
biomarkers in response to sleep loss, Tartar and colleagues (2015) examined whether
volitional and chronic sleep restriction impacted participants’ psychological and physical
health. In particular their study examined a female-specific sample’s (N = 60) cortisol
levels on the basis of total sleep time and sleep delay. More specifically, their study was
divided into two groups on the basis of sleep time, such that participants sleeping fewer
than seven hours were deemed chronically sleep restricted, whereas the other group was
deemed non-chronically sleep restricted. Results indicated a positive relationship between
cortisol levels and a later time to fall asleep, although amongst the chronically sleeprestricted group, this relationship only persisted when accounting for a later time to fall
asleep (Tartar et al., 2015). Finally, the non-chronically sleep restricted group did not
significantly differ from the chronically sleep restricted group in terms of cortisol levels
when both groups did not delay their time to fall asleep. Thus, in isolation, cortisol was
significantly correlated with delayed sleep time. The authors reasoned that chronically
achieving fewer than seven hours of sleep conceivably constitutes a physiological
stressor, thus underscoring elevations in cortisol via the hypothalamic-pituitary-adrenal
axis (Tartar et al., 2015). However, it should be noted that precautions were not taken to
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account for participants’ menstrual cycle phase, thus raising the possibility that an altered
cortisol awakening response confounded the results (LeRoux et al., 2014).
Similarly, in a study comprising exclusively females (n = 15) aged 18-25, Omisade et
al., (2010) found that, compared to non-sleep restricted individuals, participants’ peak
morning cortisol levels tapered off at a slower rate over the course of the day, meaning
that their levels were elevated in the evening hours. They indicated that elevations in
evening levels of cortisol are associated with decreased leptin and increased ghrelin, and
stated that it is worth considering whether these hormonal changes stem from the
flattened diurnal pattern seen in cortisol secretion following sleep restriction. Thus, it
remains unclear as to whether the specific mechanism leading to these physiological
changes are a result of discrete elevations in cortisol levels over the course of the day, or
rather, an altered pattern. What also remains unclear is how men and women’s cortisol
levels and patterns are differentially impacted following sleep restriction, although
evidence (i.e., Kumari et al., 2009) suggests that they may in fact experience it in a
similar manner. As was repeatedly mentioned, there is a stark lack of research that has
addressed women, therefore also having the consequence of having a poverty of studies
comparing men and women, further obscuring our understanding. In addition, the specific
manipulations (e.g., number of hours restricted, number of days restricted, method of
monitoring the restriction) that were employed to restrict sleep differed, thus it is unclear
to what extent these may have impacted the results, although it appears as though the
baseline conditions were relatively consistent between studies. In all, there is mounting
evidence that would suggest altered cortisol patterns in response to altered sleep patterns,
yet our understanding is far from comprehensive.
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IL-6. In terms of IL-6, it is an inflammatory marker involved in a variety of pro- and
anti-inflammatory functions, having endocrine and metabolic effects (Agorastos et al.,
2014). More specifically, IL-6 is implicated in acute immune responses, thyroid function,
as well as the secretion of C-reactive protein. Vgontzas et al., (2004) articulate that IL-6
and sleep restriction are intrinsically linked, such that in the face of sleep loss, IL-6 levels
increase, having consequences in the form of insulin resistance, osteoporosis, and
cardiovascular disease. Further, elevations have also been associated with obesity, aging,
morbidity, and mortality (Vgontzas et al., 2004). IL-6 follows a diurnal pattern, and this
too, can become disrupted in the face of disrupted sleep. Agorastos and colleagues (2014)
indicate that IL-6 concentrations are generally lower over the course of the day and
increase overnight, but are prone to ‘rhythmic oscillations’ - alterations in one’s circadian
circulating IL-6 concentrations, following sleep deprivation.
Like cortisol, IL-6 has reportedly received insufficient attention in sleep research,
particularly as it pertains to chronic sleep restriction versus acute sleep deprivation
(Banks & Dinges, 2007), as well as whether gender moderates the relationship between
sleep and IL-6 (Hong, Mills, Loredo, Adler, & Dimsdale, 2005). For instance, the vast
majority of existing studies have disproportionately included men (i.e., Lekander et al.,
2013) , and those that have included both genders have inconsistently yielded differences
(Mullington, Haack, Toth, Serrador, & Meier-Ewert, 2009). Of the studies that have
included women, gender differences in inflammatory response following sleep loss tend
to not be reported, as the studies were not powered to test for differences (Mullington et
al., 2009), although there is one exception that demarcates gender differences (e.g.,
Vgontzas et al., 2004).
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In addition to cortisol, Vgontzas et al., (2004) examined the impact that sleep
restriction has on participants’ IL-6 levels. Results did not reveal an effect of gender, as
sleep restriction was associated with increased levels of IL-6 across both sexes.
Moreover, Shearer and colleagues (2001) examined whether two different sleep
manipulations (i.e., sleep restriction vs. sleep deprivation) interfered with markers of
immunity, including IL-6. Their study comprised exclusively of males (n = 42), who
were randomly assigned to either restrict their sleep to two hours per day, or to refrain
from sleeping, thus deprive themselves for a period of four days. Results indicated that
participants who underwent four days of sleep deprivation exhibited significant increases
in plasma levels of IL-6, but that the group undergoing sleep restriction did not. They
reasoned that the two-hour period of sleep may have been sufficient to prevent the
immune changes observed within the total sleep deprivation group.
Further, Vgontzas et al., (2002) conducted a study in which levels of IL-6 in
participants with insomnia were compared to those of age and body mass index-matched
controls. The insomnia group included six men and five women, whereas the control
group included eight men and three women. Insomnia was determined on the basis of
whether participants reported sleeping less than 6.5 hours per night, at least four nights a
week, for a span of at least six months and/or requiring 45 minutes or more to fall asleep.
Participants’ slept in a sleep laboratory for four consecutive nights. Results indicated that
mean levels of IL-6 secretions did not differ between the insomnia and control group,
although the timing of IL-6’s peak secretion occurred earlier in the evening amongst the
participants with insomnia, relative to those in the control group, whose peak IL-6
secretion occurred throughout the nighttime. The authors reasoned that IL-6’s shifted
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time of peak secretion may account for insomniacs’ greater difficulty falling asleep, thus
accounting for the greater daytime sleepiness experienced. While the study comprised
both males and females, information related to a gender-interaction was unavailable.
In contrast, Suarez (2008) found an effect of gender in the relationship between poor
sleep quality and inflammatory biomarkers. In other words, self-reported poor sleep
quality, as measured by the Pittsburgh Sleep Quality Inventory (PSQI), was related to
enhanced levels of IL-6 in women (Suarez, 2008). His study included 95 women and 115
men. Results indicated that PSQI score correlated positively with IL-6 in women and not
men, and that specific symptoms of poor sleep gauged from the PSQI accounted for the
majority of this relationship. In particular, greater and more frequent bouts of difficulty
falling asleep were positively associated with elevations of IL6 exclusively amongst
female participants. Suarez (2008) concludes that his results underscore why women are
more likely to incur cardiovascular difficulties such as hypertension compared to men as
a result of sleep disturbances. While poor sleep quality does not necessarily serve as a
substitute for sleep deprivation or restriction, it does provide evidence that subjective
reports of sleep loss also correlate positively with elevated inflammatory markers, such as
IL-6.
In accordance with Suarez’s (2008) findings, Irwin et al. (2010) found that one night
of partial sleep deprivation in which participants (11 women and 15 men) were awake
between the hours of 23:00 and 3:00, preceded greater IL-6 morning production
compared to levels of IL-6 following uninterrupted sleep. Interestingly, while males and
females did not differ in IL-6 morning elevations following interrupted sleep, they did
differ with respect to their IL-6 levels the following day (Irwin et al., 2010). In other
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words, relative to males, the female participants exhibited increases in IL-6 in the
evening hours the day following partial sleep deprivation. Importantly, however, testing
was not restricted to a particular phase of women’s menstrual cycle (Irwin et al., 2010),
which may have inadvertently impacted their results.
In a study comprising exclusively of males (N = 9), Lekander and colleagues (2013)
incorporated a within-subjects sleep restriction model, in which participants’ sleep was
restricted to four hours per night for a span of five days. This followed an initial baseline
phase in which participants slept eight hours per night for a span of three nights, and
preceded a recovery period in which participants again slept eight hours per night for a
span of three nights. Results indicated that, on the basis of self-report, participants
reported a decrement in subjective health as well as an increase in fatigue (Lekander et
al., 2013). With respect to IL-6, it did not change significantly following sleep restriction,
raising the possibility that the participants’ sleep had not been restricted for a long
enough span. In addition, the authors questioned whether gender may have played a role,
in that females’ IL-6 has been shown to change following sleep restriction across other
studies (i.e., Irwin et al., 2010), and theirs included a sample devoid of females.
An additional study solely composed of male participants (N = 19) found that sleep
restriction resulted in significantly elevated levels of IL-6 relative to the participants’
baseline levels (van Leeuwen et al., 2009). More specifically, participants first underwent
a two-day baseline period in which they slept eight hours per night. This was followed by
a five-day restriction period in which sleep was reduced to four hours in bed. Finally,
they underwent a recovery period of three days in which they slept eight hours per night.
As stated, sleep restriction resulted in increased activation of IL-6 synthesis.
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Interestingly, the specific sleep restriction manipulation employed throughout van
Leeuwen et al.,’s (2009) largely mirrored that of Lekander et al.,’s (2013), although
producing different results, thus calling into question Lekander et al.,’s (2013) stipulation
that their participants’ sleep had not been restricted for a long enough period.
Finally, Hong and colleagues (2005) examined the relationship between various
indicators of sleep architecture and IL-6 amongst a sample of males (n = 36) and females
(n = 34). Participants’ sleep was monitored for two consecutive nights using
polysomnography, and IL-6 was collected upon awakening on both mornings. Results
revealed positive correlations between IL-6 levels and REM latency, and wake after sleep
onset, whereas negative correlations between IL6 and sleep efficiency and slow wave
sleep were found (Hong et al., 2005). Interestingly, gender was significantly associated
with sleep efficiency, percentage of stage 1 sleep, wake after sleep onset, in that women
exhibited reduced time in stage 1 sleep, longer sleep times, and reduced waking after
sleep onset. In other words, women exhibited less fragmented sleep, increased amounts
of deep sleep, and greater sleep efficiency relative to men. As this pertains to IL6, Hong
et al. (2005) specified that the relationships between IL6 and sleep efficiency and wake
after sleep onset were stronger amongst the male participants in their study. Thus,
suggesting that gender differences in sleep architecture in relation to IL-6 are apparent.
Although this does not serve as a substitute for sleep restriction, these results underscore
the importance of accounting for gender when examining the relationship between sleep
and markers of inflammation, such as IL-6.
IL-1ß. Compared to IL-6, IL-1ß has received far less attention with respect to its
relationship with sleep, although preliminary evidence (i.e., Krueger, 2008) has linked
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sleep restriction to elevations in IL-1ß, having subsequent consequences related to
cognition, memory, pain sensitivity, and mood. For instance, Krueger (2008) indicates
that the relationship between sleep deprivation and IL-1ß results in symptoms associated
with sensitivity to kindling, pain stimuli, cognition, memory, impairments in
performance, depression, sleepiness, and fatigue. Further, he details ensuing health
consequences in the form of metabolic syndrome, chronic inflammation, and
cardiovascular disease (Krueger, 2008). IL-1ß follows a comparable diurnal pattern to IL6, such that it is lower over the course of the day, and peaks around bedtime (Okun &
Coussons-Read, 2010). Okun and Coussons-Read (2010) detail IL-1ß as a cytokine
having a crucial role in both sleep and immunity, and describe it as having an interplay
between the immune, endocrine, and sleep-wake cycle. Further, IL-1ß is implicated in the
body’s response to infection and injury, including how it responds to pathogens (LopezCastejon & Brough, 2011). Additional evidence suggests that IL-1ß and sleep are
intrinsically tied, such that IL-1ß administration amongst both humans and animals has
been associated with spontaneous sleep and fatigue (Jewett & Krueger, 2012). Similarly,
disruptions in rats’ sleep has been associated with elevations in IL-1ß (Zielinski, Kim,
Karpova, McCarley, & Strecker, 2014).
Because it is so intimately tied to the body’s sleep-wake cycle, it is not surprising that
disruptions in one’s sleep leads to disruptions in IL-1ß. For instance, Covelli et al., (1992)
found significant differences in participants’ IL-1ß production, depending on whether
they had slept the preceding night. It should be noted that the study’s participants were all
male (N = 4), and two of the participants were unable to sleep. Relative to the participants
who did sleep, those who did not sleep, failed to exhibit any IL-1ß secretion throughout
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the study, leading the authors to conclude that normal sleep is associated with nocturnal
rises in IL-1ß, whereas altered sleep patterns are inversely related to IL-1ß secretion
(Covelli et al., 1992).
In addition to cortisol, Tartar et al. (2015) examined whether chronically and nonchronically sleep restricted individuals, who either delayed or did not delay falling asleep,
differed with respect to IL-1ß. Results indicated that IL-1ß levels were inversely related
with sleep duration, such that shortened sleep duration was associated with marked
increases in circulating IL-1ß (Tartar et al., 2015). Further, IL-1ß was also elevated
amongst the chronically sleep restricted group going to bed at a later time. Given IL-1ß’s
somnogenic factor in humans, the authors highlighted the apparent contradictory nature
of the prolonged wakefulness and shortened sleep duration evidenced by this group
(Tartar et al., 2015). These results stand in contrast with Covelli et al.,’s (1992) wherein
one night of total sleep deprivation was associated with the absence of the expected
nocturnal rise in IL-1ß. Given that Covelli et al.,’s (1992) study comprised exclusively of
males, and that Tartar et al.,’s (2015) study comprised exclusively of females, it raises the
possibility that male and females’ IL-1ß is differentially impacted as a result of sleep
loss.
Finally, van Leeuwen and colleagues (2009) also examined IL-1ß. Similar to IL-6,
they reported an increase following sleep restriction, and sustained elevations throughout
the recovery phase. Like Covelli et al.,’s (1992) study, van Leeuwen and colleagues’
(2009) study solely included male participants, yet their results are not comparable. In
other words, Covelli and colleagues (1992) reported that following one night of total
sleep deprivation, participants did not exhibit the expected nocturnal rise in IL-1ß.
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Conversely, five days of sleep restriction resulted in sustained elevations in IL-1ß among
the participants in van Leeuwen and colleagues’ (2009) study. The divergent results raise
several possibilities including whether the specific manipulation induced the divergent
results, or whether the small sample size (N = 4) in Covelli et al.,’s (1992) study was
sufficient to produce replicable and generalizable results.
As stated, there is a stark lack of research examining IL-1ß in the context of sleep loss
involving either sexes. While there is reason to believe that it is altered as a result of
disrupted sleep, little research has addressed to what extent this occurs, and whether
females are impacted by this in a differential manner compared to males. While IL-1ß in
particular has been understudied in the context of sleep loss, as it stands, our
understanding of how other biological markers, including IL-6 and cortisol are impacted
is also far from clear. What is especially unclear is whether, and to what extent, women
are differentially impacted following sleep loss compared to males. As a testament to this
uncertainty, it has yet to be established whether men or women are most resilient to the
effects of sleep loss, with certain studies (i.e., Vgontzas et al., 2004) suggesting that
females are more resilient, whereas others (i.e., Suarez, 2008) state that females incur the
greatest detriments in their psychological and physiological health. By virtue of their
distinct hormonal composition, it is inherently a more complex process to examine
biological changes in response to sleep loss amongst women. Therefore, in the absence of
properly controlled studies examining women’s biological markers in response to sleep
loss, statements regarding which gender is most at risk (for encountering the deleterious
effects associated with sleep loss) and how women’s pro-inflammatory cytokines, as well
as glucocorticoids are impacted, cannot be ascertained with confidence.
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Psychological Consequences
With regards to psychological indices, as was described previously, there is a high
prevalence of women impacted by sleep pathologies, yet this is far from a complete
picture. In other words, not only do women comprise a significant proportion of those
diagnosed with sleep problems, but they also encounter profound difficulties as a result
of their poor sleep quality (Mallampalli & Carter, 2014). For instance, chronic insomnia
has been linked with heightened levels of depression, rumination, chronic anxiety,
inhibited emotions and anger (Basta et al., 2007). Not only does poor sleep induce
additional psychological problems, but existing psychopathologies (e.g., depression,
bipolar disorder, etc.) are also frequently associated with impaired sleep (Basta et al.,
2007). Thus, there is evidence to suggest that the relationship between sleep and
psychopathology is bidirectional. Traditionally, this relationship has been conceptualized
from the perspective of poor sleep quality leading to reduced psychological well-being.
However, there is a body of clinical research that has examined how sleep deprivation
may actually serve to reduce symptoms of depression (Wirz-Justice & Van den
Hoofdakker, 1999).
More specifically, depriving depressed patients’ sleep may alleviate symptoms of
depression, an intervention referred to as induced-wakefulness therapy (Hemmeter,
Hemmeter-Spernal, & Krieg, 2010). While the majority of studies involving inducedwakefulness therapy have incorporated a sleep deprivation paradigm, Hemmeter and
colleagues (2010) report that partial sleep deprivation, or sleep restriction, may be as
effective in reducing depressive symptomatology. Of importance, the clinical effects
observed are short-lived (Wirz-Justice & Van den Hoofdakker, 1999), and are often
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unstable (Hemmeter et al., 2010); despite this, the approach has been efficacious for a
broad range of individuals, regardless of their gender, age, number of hospitalizations,
and severity of symptomatology (Hemmeter et al., 2010). However, restricting a nondepressed individual of their sleep leads to diminished positive affect, and may induce a
manic or hypomanic state in up to 25% of individuals with bipolar disorder (Hemmeter et
al., 2010; Wirz-Justice & Van den Hoofdakker, 1999), further reinforcing the notion of
how intrinsically linked sleep duration and psychological well-being are. Additionally, in
a study comprising exclusively of females (N = 621), de Wild-Hartmann et al. (2013),
found that “measures of sleep were good predictors of subsequent daytime affect,
whereas measures of affect did not predict subsequent sleep. Notably, negative affect did
not have an impact on subsequent sleep” (p. 410). Meaning, subjective reports of poor
sleep quality lead to a reduction in self-reported positive affect, whereas the reverse did
not hold true.
There exists strong agreement within the literature with regards to how sleep and
psychological well-being mutually impact one another (Bower, Bylsma, Morrris, &
Rottenberg, 2010; de Wild-Hartmann et al., 2013; Kahn, Sheppes, & Sadeh, 2013;
Minkel et al., 2010; Steptoe et al., 2008; Tartar et al., 2015). For instance, sleep
deprivation may result in enhanced anxiety and depressive symptomatology amongst
non-clinical samples (Hemmeter et al., 2010; Kahn et al., 2010). Further, Dinges et al.,
(1997) found that participants (eight females and eight males) reported an increased
global score of mood disturbance following seven days of sleep restriction that required
participants to restrict their sleep to five hours per night. In addition, they also found that
participants’ reported levels of tension-anxiety, confusion, and fatigue increased (Dinges
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et al., 1997). Information regarding main effects of gender or interactions in the context
of mood and sleep restriction were not highlighted. While biological samples were not
collected, Dinges et al. (1997) denied taking steps to account for the females’ menstrualcycle phase, which may have inadvertently impacted their results, given that Mallampalli
and Carter (2014) report that the rate at which women report sleep problems increases the
week prior to menstruation.
Similar to Dinges and colleagues’ (1997) findings, Tartar et al., (2015) reported that
sleep loss and delayed sleep both independently contribute to decrements on clinical
health measures. As stated, their study was composed entirely of female participants (N =
60) grouped on the basis of number of hours slept and whether time to sleep was delayed
– information derived from a self-report questionnaire on sleep quality. Results indicated
that sleep restriction, as defined by sleeping fewer than seven hours per night, was
associated with reduced psychological functioning (Tartar et al., 2015). More
specifically, significant correlations between sleep quality, insomnia severity, and
sleepiness were found with increased total mood disturbance, perceived stress, and
depressive symptomatology. Participants in the chronically sleep restricted group
reported poorer sleep quality, increased reports of insomnia, as well as increased
depressive symptomatology, whereas the non-chronically sleep restricted participants
reported higher scores on attitude to life, better physical health, better environment health
(Tartar et al., 2015). In other words, self-reported sleep restriction and a later time to bed
were both associated with reduced measures of psychological health. While it was not
specified whether measures were taken to account for the participants’ menstrual cycle
phase, the results support the notion that chronically sleep restricted individuals
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encounter deleterious effects in the realm of psychological well-being. Further, it
provides evidence that routinely achieving fewer than seven hours per night produces
deleterious effects amongst female participants in particular, a claim that cannot be made
on the basis of Dinges et al.,’s (1997) results.
With respect to sleep and its relationship to stress, Minkel et al., (2012) examined
whether sleep deprived participants (one night of total sleep deprivation) differed
compared to non-sleep deprived participants (one night consisting of nine hours of sleep)
in both a low- and high-stress condition. Their study included 30 participants, with an
equal number of men and women. In short, the stress manipulations involved mental
arithmetic, with the low-stress condition having comparatively easier problems than the
high-stress condition - where participants also received negative feedback to their
responses. Results indicated that the sleep deprived participants exhibited elevated levels
of subjective stress, anger, and anxiety throughout the low-stress condition, but that
participants in both conditions exhibited comparable levels of these indicators throughout
the high-stress condition. The authors reasoned that the sleep deprivation manipulation
likely lowered the participants’ threshold for enduring the stressful task, and therefore
exhibited greater distress in the low-stress condition. Again, no information regarding
main effects of gender or interactions was provided.
While Minkel et al., (2012) provided evidence that sleep deprivation results in a
diminished threshold for enduring stressful tasks, additional research suggests that sleep
loss may also hinder lower one’s threshold for emotional regulation (Baum, Desai, Field,
Miller, Rausch, & Beebe, 2014). In their study consisting of an equal number of males
and females (N = 50), Baum and colleagues (2014) found that following five nights of
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sleep restriction consisting of 6.5 hours of sleep, participants exhibited elevated scores on
mood disturbance indices. In particular, a decrement in mood was noted, as evidenced by
increased tension, anger, anxiety, fatigue, confusion, helplessness, forgetfulness, and
exhaustion, and a drop in energy, alertness, and efficiency was also reported (Baum et al.,
2014). Participants also endorsed feeling increasingly “on edge”, nervous, and restless. It
should be noted that the study’s participants did not endorse heightened depressive
symptomatology, and the authors reasoned that this may be attributable to the age range
of the participants. More specifically, the participants ranged from the ages of 14-17, and
Baum et al., (2014) argued that depressive symptoms may instead manifest as increased
irritability amongst adolescents. Given that the current study will be examining collegeaged students, some of whom are adolescents, having an awareness that mood
decrements may manifest as irritability is valuable.
While the majority of research has traditionally linked sleep problems to indicators of
negative affect, increasing amounts of research have begun incorporating indicators of
positive affect (i.e., Bower et al., 2010; Haack & Mullington, 2005; Steptoe et al., 2008).
For instance, in a study consisting of 14 females and 26 males, Haack and Mullington
(2005) found that participants randomly assigned to restrict their sleep to 4-hours per
night exhibited diminished levels of optimism-sociability compared to the group that
slept 8-hours per night. This took place over the course of 12 consecutive nights.
Interestingly, they noted that the sleep-restricted participants’ levels of optimismsociability declined steadily over the course of the week. Information related to main
effects or interactions of gender were not discussed.
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Similarly, Bower et al., (2010) conducted a study in which sleep quality and affect
were examined. Their study included 96 participants (75% female), that were divided into
three groups on the basis of diagnosis; more specifically, 35 participants were in the
major depression group, 25 participants were in the minor depression group, and 36
participants were in the control group – a group with no history of psychopathology.
Bower and colleagues (2010) indicated that groups were matched on the basis of age,
ethnicity, and gender. Sleep quality was assessed using the PSQI. Results indicated that
participants who reported poor sleep quality evidenced elevated negative affect and
reduced positive affect. Interestingly, poor sleep quality no longer significantly predicted
negative affect once the impact of depression status was accounted for. This stands in
contrast with the relationship between sleep quality and positive affect, which persisted
regardless of depression status.
Finally, Steptoe and colleagues (2008) examined the relationship between positive
affect and wellbeing, and how these relate to reported sleep problems. The study included
486 men and 250 women, all of whom were asked to complete measures related to
positive affect, eudaimonic wellbeing, and sleep problems (as measured by the Jenkins
Sleep Problems Scale). Results indicated self-reported positive affect and eudemonic
well-being were correlated with fewer self-reported sleep problems. With respect to
gender differences, women exhibited significantly higher scores on the sleep problems
scale, and men exhibited elevated positive affect and eudaimonic wellbeing.
In all, it is evident that the relationship between poor sleep quality and quantity and
mood disturbance is well established. Nonetheless, certain gaps and limitations are quite
prominent. Most notably, it has been reported that subjective measures of sleep do not
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necessarily approximate an individual’s objective sleep and mood (de Wild-Hartmaan et
al., 2013), therefore calling into question the external validity of the studies, typically
employing a self-report methodology involving sleep quality (i.e., Bower et al., 2010) or
problems (i.e., Steptoe et al., 2008). Further, it appears as though sleep deprivation
manipulations are more frequently encountered throughout the literature, and while
important, it does not represent the type of short sleep duration most frequently
encountered in the general population. Moreover, women have been shown to experience
psychological problems in a different manner compared to men (Mallampalli & Carter,
2014), which tend to follow poor sleep, rather than precede it (de Wild-Hartmann et al.,
2013). It is therefore surprising that studies (i.e., Dinges et al., 2007; Haack &
Mullington, 2008; Minkel et al., 2012) that have examined the interplay of psychological
well-being and sleep have not partialed out main effects or interactions involving gender.
Generally, little research has included a female-specific population as a means for further
elucidating this gender’s combined experience of short sleep and affect, which may likely
be different from that of males’. Despite there being a strong body of literature examining
the impact that short sleep has on ensuing mood, our understanding is far from
comprehensive, especially in light of these limitations.
Neurocognitive Consequences
Like the biological and psychological realms of behavioral sleep research, the
neurocognitive consequences following sleep restriction have received far less attention,
relative to the consequences following sleep deprivation (Stenuit & Kerkhofs, 2008). Of
the studies that have examined the neurocognitive consequences of sleep restriction, tests
such as the “Wilkinson Auditory Vigilance” or the “Psychomotor Vigilance Test” (PVT)

30
have frequently been employed (Belenky et al., 2003; Dinges et al., 1997; Stenuit &
Kerkhofs, 2008), and results have consistently shown that restricted sleep produces
increased reaction times. The relative impact of sleep restriction on other neurocognitive
variables, such as attention, memory, language-based tasks, visuo-spatial ability, motor
performance, mental arithmetic, and executive functions such as mental flexibility,
divided attention, verbal fluency, and inhibition are not as well understood (Stenuit &
Kerkhofs, 2008). To further complicate our understanding, a large proportion of sleep
restriction studies that have examined neurocognitive variables have also been biased
towards including a male, rather than a female or mixed-gender sample (e.g., Belenky et
al., 2003; Faraut et al., 2012). Given that females have been shown to encounter the
deleterious effects of sleep restriction in a different capacity than men, such as enhanced
deficits on tasks of vigilance, including the PVT (Stenuit & Kerkhofs, 2005), and that
extant results on the neurocognitive consequences of sleep restriction are mixed, it is
evident that there is a need for replications of prior paradigms involving female-specific
samples.
In a comprehensive review of the literature, Waters and Bucks (2011)
summarized the neuropsychological effects of sleep loss, which they defined as routinely
achieving less than seven hours of sleep. Specific consequences on one’s
neuropsychological functioning following sleep loss include decrement in working
memory, divided attention, inhibition, verbal fluency, and problem solving. In addition,
increased response time on the Digit Symbol Modality Test and Trail Making Tests, as
well as a reduction in performance on tests of attention and vigilance, such as the PVT
have been noted (Martin, Engleman, Deary, & Douglas, 1996). There is also evidence of
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diminished mental arithmetic performance in the form of slower performance and an
increase in number of errors made and interestingly, this was a linear relationship, in that
the longer an individual had been sleep deprived for, the worse their performance (Van
Dongen, Maislin, Mullington, &Dinges, 2003). Further, Pilcher et al., (2007) reported
decreased performance on language-based and speech tasks, motor tasks, and social
cognition following sleep loss, such that sleep deprived participants exhibited a reduction
in expressive language, as evidenced by a notable decrease in the number of
spontaneously produced words. With respect to motor performance, approximately a 30%
decrease in hand-eye coordination performance, particularly in the realms of speed and
accuracy have been reported (Williamson & Feyer, 2000). Consequences in terms of
one’s social cognition have also been documented, in the form of deficits in emotional
decision-making, interpersonal functioning, and moral judgment (Killgore, Balkin, &
Wesenstem, 2006).
Stenuit and Kerkhofs (2008) conducted a study wherein the neurocognitive effects of
sleep restriction were assessed amongst a female sample (N = 20). The study took place
over the course of five nights. The first night, the baseline, participants slept from 11 pm
to 7 am. The following three nights, the participants’ sleep was restricted, and they slept
from 1 am to 5 am. The last night was their recovery night and they slept from 11 pm to 7
am. They assessed the participants’ cognitive functioning in the following three domains:
attention, memory, and abstraction. Attention was assessed using selective and divided
attention tasks and tasks requiring the inhibition of automatic processes (e.g., the Stroop
test, Trail Making Test - Part B). Memory was assessed using tasks of visual, auditory,
and logical memory (e.g., Buschke 16 items, Paced Auditory Serial Task, etc.).
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Abstraction was assessed using the Wisconsin Card Sorting Task (WCST), a measure of
cognitive flexibility that is particular attuned to frontal lobe dysfunction.
In all, results supported previous findings that demonstrate an increase in reaction
time following sleep restriction (Stenuit & Kerkhofs, 2008). Additionally, they found
diminished performance on tasks requiring the inhibition of automatic activity (e.g.,
Stroop task) and those requiring the formation of a memory trace (e.g., Buschke’s 16
items memory test). Interestingly, there was no indication that participants’ response
accuracies diminished, just that the time required to respond increased. Somewhat
paradoxically, the enhanced response latencies were accompanied by impulsiveness in
responding, in that the participants exhibited difficulties inhibiting their dominant
response in tests of attention. Interestingly, participants’ performance on the WCST, a
measure of frontal abstraction abilities did not reflect evidence of diminished
performance, thus failing to support the frontal lobe hypothesis detailed in Waters and
Bucks’ (2011) review, which posits that sleep restriction disproportionately impinges on
the frontal lobes’ ability to successfully perform its executive functions as a result of
changes in cerebral metabolism. Critics of this hypothesis, however, point out that sleep
research has failed to find consistent deficits in tasks requiring frontal functions.
Response speed is the traditional metric used to determine one’s information
processing speed, a domain which has also been shown to increase following sleep loss
(Cohen-Zion, Shabi, Levy, Glasner, & Wiener, 2016). Cohen-Zion et al., (2016)
examined adolescent participants’ (N = 41) (23 males, 18 females) processing speed in
response to both partial sleep deprivation and sleep extension. The partial sleep
deprivation condition required that participants spend six hours per night in bed for a
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span of four nights, whereas the sleep extension condition required that participants
spend ten hours in bed for a span of four nights. Results indicated that relative to the
sleep extension condition, participants in the partial sleep deprivation condition exhibited
poorer performance on tasks of information processing speed, executive function, motor
skills, and attention (Cohen-Zion et al., 2016). The authors reasoned that sleep loss
results in significant decrements in performance, whereas “sleep satiation seemed to
allow for optimal performance on components of the task that required heightened effort
or motivation.” (Cohen-Zion et al., 2016, p. 396). Thus, having implications in terms of
how individuals approach, interpret, encode, and subsequently respond to data they are
confronted with on a daily basis.
Doran, Van Dongen, and Dinges (2001) also examined the cognitive
consequences following sleep deprivation in the realms of reaction time and performance
variability. Their sample included 28 male participants, 13 of whom were placed in the
experimental group, who underwent four days of total sleep deprivation. The other group
underwent sleep restriction, and they were permitted to sleep two hours every 12 hours.
Results indicated that participants in the total sleep deprivation group exhibited greater
reaction times and greater performance variability on the PVT relative to the sleep
restriction group. Additionally, participants in the sleep deprivation group exhibited a
greater number of omission as well as commission errors, characterized by performance
variability and instability. Doran et al., (2001) remarked that the performance instability
could possibly be accounted for by the reduced attention and alertness experienced
following a period of sustained wakefulness, placing the participant in a state in between
wakefulness and sleep. In all, these results are largely consistent with those reported by
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Martin and colleagues (1996) which detail an increase in reaction time following sleep
deprivation.
Given that chronic sleep restriction is far more common of an occurrence amongst
the general population compared to sleep deprivation, it is imperative to understand
whether there are differences in how this manifests cognitively. In other words, having a
participant come into the lab and deprive them of a single night of sleep certainly
produces deleterious effects (Van Dongen et al., 2003), but how would this compare to an
individual who experiences poor sleep on a longer-term basis? In an attempt to address
these questions, Van Dongen and colleagues (2003) conducted a study wherein
participants either underwent total sleep deprivation, or chronic sleep restriction. The
total sleep deprivation group was split into three levels, such that participants’ cognitive
functioning was tested following one, two, and then three nights of total sleep deprivation
(Van Dongen et al., 2003). The chronic sleep restriction group was also divided into three
levels, and participants either slept four, six, or eight hours per night for a period of 14
days (Van Dongen et al., 2003). While eight hours of sleep per night does not constitute
sleep restriction by most standards (e.g., Alhola & Polo-Kantola, 2007), this group was
likely included as a control group. Specific cognitive areas that were assessed included
attention, working memory, and reaction time.
Not surprisingly, results indicated that the most profound deficits were seen in the
group that underwent three days of total sleep deprivation. Another expected result was
that the group that slept eight hours per night over the span of 14 days did not exhibit any
deficits (Van Dongen et al., 2003). The chronic sleep restriction group that slept six hours
per night exhibited the same deficits as participants who underwent total sleep

35
deprivation for a period of one night (Van Dongen et al., 2003). Meaning, if an individual
were to pull an ‘all-nighter’ for instance, they would exhibit the same sort of cognitive
deficits as an individual who has been moderately restricting their sleep for a period of
two weeks. These deficits included a decline in PVT and working memory performance.
Finally, the chronic sleep restriction group that slept four hours per night exhibited
deficits in attention and working memory similar to deficits exhibited in the two-night
sleep deprivation group, whereas participants that restricted their sleep to six-hours per
night exhibited comparable impairments to the one-night sleep deprivation group (Van
Dongen et al., 2003).
Importantly, out of the study’s 48 participants, no females were assigned to the
total sleep deprivation group (which consisted of 13 males), two females (and seven
males) were assigned to the eight-hour sleep restriction group, three females (and ten
males), were assigned to the six-hour sleep restriction group and finally, one female (and
12 males) was assigned to the four-hour sleep restriction group. Thus, out of the study’s
48 participants, only six were female. In light of mounting research that suggests sleep
restriction and deprivation differentially impact men and women, it is conceivable that a
sleep deprivation group devoid of any females, and sleep restriction groups that are
disproportionately male are questionable in terms of their external validity. Meaning, it is
likely that their results are more appropriately extrapolated to represent males as opposed
to females.
While it is recognized that sleep restriction leads to an increase in reaction time,
our understanding of how other neurocognitive domains such as attention, memory,
executive functioning, and verbal fluency are impacted remains far from clear (Stenuit &
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Kerkhofs, 2008). Similar to the biological and psychological realms, there exists a stark
lack of research examining the neurocognitive consequences that females encounter
following sleep restriction, as the vast majority of studies have utilized an exclusively
male (e.g., Belenky et al., 2003; Doran et al., 2001; Faraut et al., 2012) rather than a
female, or mixed-gender sample. Studies that have included women (i.e., Stenuit &
Kerkhofs, 2008) note that they encounter the deleterious effects of sleep restriction
differently than men in the form of enhanced deficits on tasks of vigilance. From a
practical standpoint, deficits in neurocognitive functioning have consequences in the
form of motor vehicle accidents, sustaining attention in the home/work environment, as
well as problem-solving everyday tasks (Short & Banks, 2014). Without a proper
understanding of whether and how women are differentially impacted, our understanding
of the functional neurocognitive consequences associated with sleep restriction are
incomplete.
Conclusion
Sleep restriction has become a characteristic feature of modern society (Stenuit &
Kerkhofs, 2008), and the average number of hours slept continues to decline to the extent
that approximately one-third of the American population is now chronically sleep
restricted (Luyster et al., 2012). While this may be attributable to a number of factors
including evolving societal pressures, cultural attitudes, and a lack of awareness, the
extent to which individuals encounter sleep-related ailments in the form of biological,
psychological, and neurocognitive functioning will inevitably increase. As it stands,
behavioral sleep medicine’s literature is plagued by a number of flaws, including a lack
of attention devoted to sleep restriction as compared to sleep deprivation (Stenuit &

37
Kerkhofs, 2008) as well as whether an individual’s functioning is differentially impacted
depending on whether their contracted amount of sleep is due to volitional or nonvolitional factors (Goel et al., 2013). A particularly prominent flaw within the literature
pertains to women’s underrepresentation or exclusion in studies (Stenuit & Kerkhofs,
2008; Suarez, 2008), or the lack of controls implemented to account for their endogenous
hormonal fluctuations (i.e., Dinges et al., 1997; Faraut et al., 2012). While there is reason
to believe that females encounter greater deleterious effects following poor sleep quality
compared to men (i.e., Suarez, 2008), our understanding is far from clear, especially
when examining the biological, psychological, and neurocognitive elements.
For instance, when examining glucocorticoids such as cortisol or pro-inflammatory
cytokines including IL-6 and IL-1ß, it has yet to established whether men or women are
most resilient to the effects of sleep loss, as certain studies (i.e., Vgontzas et al., 2004)
suggest that women are most resilient to the effects of sleep loss, whereas others (i.e.,
Suarez, 2008) report that women are most likely to encounter the deleterious effects,
relative to males. Our understanding is further clouded, as there is a lack of properly
controlled studies (i.e., Dinges et al., 2007; Faraut et al., 2012) that account for women’s
hormonal fluctuations, which have the potential to obscure fluctuations in biological
markers following sleep loss. While this is especially problematic in terms of biological
variables, what has yet to be established is whether these are measures that are as
essential when examining other variables, such as in the psychological and
neurocognitive realms. There is however reason to believe that women’s endogenous
hormonal fluctuations have the potential to impact one’s subjective report of sleep, as
Mallampalli and Carter (2014) indicated that the rate at which women report sleep
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problems increases the week preceding menstruation, and given that poor sleep precedes
a decrease in positive affect (de Wild-Hartmann et al., 2013), it stands to reason that
psychological variables, including well-being, are vulnerable to hormonal fluctuations as
well. Further, if females are reporting diminished sleep quality at greater frequencies at
certain phases of their menstrual cycle, then it also stands to reason that they are also
vulnerable to neurocognitive consequences as well. In particular, what is well established
is that increases in reaction time reliably follow sleep restriction, but similar to studies
examining biological and psychological variables, the vast majority of studies have
utilized an exclusively male (e.g., Belenky et al., 2003; Doran et al., 2001; Faraut et al.,
2012) rather than a female, or mixed-gender sample. In all, it is conceivable that some
form of pathological sleep, whether this takes the form of poor sleep quality, diminished
quantity, deprivation, or restriction, produces adverse effects in one’s functioning.
However, our ability to extrapolate these results is limited, particularly when the sleep
restriction is specifically encountered at an increasingly high rate in the American
population. What is also limited is our ability to make specific claims regarding how
women in particular are impacted. Thus, there is a crucial need to examine whether and
to what extent females’ biological, psychological, and neurocognitive functioning is
affected following sleep restriction that is either naturally occurring or imposed in an
experimental manner.
Hypotheses
It is apparent that sleep problems precede a host of deteriorations in the biological,
psychological, and neurocognitive realms. Despite this, our understanding of how sleep
restriction in particular, impacts women, relative to males, is far from comprehensive, as
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evidenced by the limited number of studies including women, or allotting women
necessary representation relative to men. Given that sleep restriction best approximates
the current state of sleep in the general population, there is a pressing need to identify its
consequences. As a means for addressing these gaps and inconsistencies, the current
study will attempt to uncover how females’ biological, psychological, and neurocognitive
functioning is impacted depending on whether their sleep is restricted in an acute manner,
or whether it is restricted in a chronic manner. In other words, we will examine
participants who, without any experimental manipulation, sleep an average of less than
seven hours per night and also report reduced sleep quality. These participants are
referred to as naturally sleep restricted (NSR). Conversely, participants who sleep
between seven and nine hours per night, and do not report reduced sleep quality will
undergo an experimental manipulation that restricts their sleep. These participants are
referred to as experimentally sleep restricted (ESR).
Research question 1.1. Are there significant differences between NSR and ESR
groups on biological markers of health?
First, we hypothesize that at baseline, the NSR group will have elevations relative to
the ESR group (i.e., prior to any sleep restriction manipulation). Second, following sleep
restriction, we hypothesize that the ESR group will have elevations on their biological
markers of health relative to the NSR group.
Research question 1.2. Are there significant differences between baseline and post
sleep restriction on biological measures of health in the ESR group?
We hypothesize that the ESR group will exhibit elevations on biological measures
following a week of sleep restriction.
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Research question 2.1. Are there significant differences between NSR and ESR
groups on psychological markers of health?
First, we hypothesize that at baseline, the NSR group will exhibit reduced
psychological functioning relative to the ESR group (i.e., prior to any sleep restriction
manipulation). Second, following sleep restriction, we hypothesize that the ESR group
will exhibit reduced psychological functioning relative to the NSR group.
Research question 2.2. Are there significant differences between baseline and post
sleep restriction on psychological measures of health in the ESR group?
We hypothesize that the ESR group will exhibit reduced psychological functioning
following a week of sleep restriction.
Research question 3.1. Are there significant differences between NSR and ESR
groups on neurocognitive markers of health?
First, we hypothesize that at baseline, the NSR group will exhibit reduced
neurocognitive functioning relative to the ESR group (i.e., prior to any sleep restriction
manipulation). Second, following sleep restriction, we hypothesize that the ESR group
will exhibit reduced neurocognitive functioning relative to the NSR group.
Research question 3.2. Are there significant differences between baseline and post
sleep restriction on neurocognitive measures of health in the ESR group?
We hypothesize that the ESR group will exhibit reduced neurocognitive functioning
following a week of sleep restriction.
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Chapter 3: Method
Participants
Twenty healthy participants divided in two groups were included in the study. There
were 11 participants in the Naturally Sleep Restricted (NSR) group, and 9 participants in
the Experimental Sleep Restriction Group (ESR). All participants were female, and
ranged from 18 to 22 years old (M = 19.65 ± SD 1.182). In order to be included in the
study, participants had to meet certain inclusion criteria, which were ascertained during a
preliminary telephone interview. In order to be included, participants denied having
trouble sleeping, receiving a formal diagnosis related to sleep or psychiatric functioning,
or using any drugs and/or medications that would interfere with their sleep. In order to be
included, all participants needed to be females between the ages of 18-35. If participants
met the inclusion criteria, an initial meeting in the laboratory was scheduled, in which the
Mini International Neuropsychiatric Interview (MINI) (Sheehan et al., 1998) was
administered to ascertain that participants did not meet criteria for a psychiatric
condition.
Determination of group assignment was based on normality of sleep, as determined
by the following: average number of hours slept throughout an initial baseline week
(recorded via actigraphy), score on the Insomnia Severity Index (ISI) (Morin, 1993), and
the Pittsburgh Sleep Quality Inventory (PSQI) (Buysse, Reynolds, Monk, Berman, &
Kupfer, 1989). Generally, if participants slept an average of less than 7 hours per night,
scored above a 5 on the PSQI, and above an 8 on the ISI, these sufficed as indicators of
reduced sleep quality; viewed in conjunction with one another, these participants were
placed in the NSR group. If they slept between 7-9 hours and had scores on the ISI and
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PSQI that were within normal limits, they were placed in the ESR group (see Appendix
A).
Due to the confounding effects of hormones throughout the menstrual cycle’s
follicular phase, all participants biological samples were collected throughout the luteal
phase of their cycle. The two groups did not differ significantly with respect to age or
body mass index (see Appendix B), and all were students enrolled in an undergraduate
program. The study was approved by the Internal Review Board at Nova Southeastern
University. All women gave a written informed consent. The participants received
financial compensation in the form of a gift card for their involvement in the study.
Measures/Materials
Screening measure. Participants who met initial inclusion criteria were
scheduled for further screening of possible psychiatric condition via a clinical interview.
This was completed using the Mini International Neuropsychiatric Interview (MINI)
(Sheehan et al., 1998).
MINI. The MINI is a diagnostic interview that focuses on the diagnosis of mental
disorders in addition to suicidality based on the Diagnostic and Statistical Manual IV
(DSM-IV) and the International Classification of Diseases 10 (ICD-10), and its
administration takes approximately 15 minutes (Hyphantis, Kotsis, Voulgari, Tsifetaki,
Creed, & Drosos, 2011). The MINI entails branching tree logic, such that if a participant
or patient endorses symptoms associated with a particular disorder, then a more in-depth
screening of that disorder will take place (Hyphantis et al., 2011). Inter-rater reliability as
well as test-retest reliability of the MINI compared to the Structured Clinical Interview
for DSM (SCID) and the Composite International Diagnostic Interview (CIDI)
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demonstrate that the MINI yields valid and reliable DSM-IV diagnoses (Hyphantis et al.,
2011).
Sleep measures. Sleep was assessed using questionnaires and actigraphy. More
specifically, the Insomnia Severity Index (ISI) (Morin, 1993) and the Pittsburgh Sleep
Quality Inventory (PSQI) (Buysse et al., 1989) were administered as screening measures
to identify participants’ reported symptoms of insomnia and sleep quality. Throughout
the experiment, objective measures of sleep were collected using actigraphy (Actiwatch
Spectrum Plus, Philips Respironics) and a daily sleep diary.
ISI. The ISI is a 7-item self-report questionnaire that assesses insomnia severity
(Morin, 1993). The ISI has a cut-off score of 8, which is suggestive of sub-threshold
insomnia (Morin et al., 2011). Scores ranging from 0-7 indicate the absence of insomnia,
scores ranging from 8-14 indicate sub-threshold insomnia, scores ranging from 15-21
indicate moderate insomnia, and scores ranging from 22-28 indicate severe insomnia
(Morin et al., 2011). It has strong internal consistency for clinical samples having
insomnia and those without, demonstrating Cronbach’s alpha estimates of 0.90 and 0.91,
respectively (Morin, Belleville, Belanger, & Ivers, 2011). Morin et al., (2011) report that
the ISI exhibits strong convergent validity, as it correlates strongly with the PSQI (r =
0.80), and also exhibits significant correlations with measures of anxiety and depression,
as well as different dimensions of fatigue and quality of life, all of which are variables
associated with insomnia.
PSQI. The PSQI is a 19-item assessment of sleep quality that includes 7
components, including subjective sleep quality, sleep latency, sleep duration, habitual
sleep efficiency, sleep disturbances, use of sleep medications, and daytime dysfunction,
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which are derived based on responses to the assessment’s 19 items (Buysse et al., 1989).
It also provides a global component score of sleep quality. It has a cutoff score of 5,
which distinguishes good sleepers from poor sleepers (Smith & Wegener, 2003). The
PSQI exhibits high internal consistency, with Cronbach’s alpha of 0.83 for the global
component score, and correlation coefficients for component to global scores ranging
from 0.35 (sleep disturbance) to 0.76 (habitual sleep efficiency and subjective sleep
quality) (Smith & Wegener, 2003). Further, there is also a strong intercorrelation
coefficient of 0.83 among the items (Smith & Wegener, 2003). With respect to validity,
many PSQI components correlated significantly with sleep diary scores, providing
evidence of criterion validity. In particular, amongst a sample of participants diagnosed
with primary insomnia, PSQI estimates of sleep duration (r = 0.81, p < .001) and sleep
latency (r = 0.71, p < .001) correlated significantly with sleep diary estimates.
Actigraphy. Actigraphy provides an objective estimate of participants’ sleep
quantity and quality, is worn like a watch, and is sensitive to motion (Sciberras et al.,
2010). The ‘gold standard’ of sleep assessment is polysomnography, but due to
limitations surrounding its implementation (i.e., cost, transportation, etc.), actigraphy has
been explored as an alternative (Aili, Åström-Paulsson, Stoetzer, Svartengren, & Hillert,
2017). Sadeh, Hauri, Kripke, and Lavie (1995) report that actigraphy is a valid measure
of sleep, having significant correlations with polysomnographic measures of total sleep
period (r = 0.90), total sleep time (r = 0.89), and wake after sleep onset (r = 0.70).
Biological measures. The specific biological measures that were employed
assessed participants’ cortisol, IL-6, and IL-1β. Saliva samples were run in duplicate and
measured using human enzyme immunoassay kits per the manufacturer’s instructions
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(Salimetrics LLC, USA). All samples, which were within the detection ranges specified
in the immunoassay kits, were read in a BioTek ELx800 plate reader (BioTek
Instruments, Inc, USA) at 450 nm with a correction at 630 nm. The variation of cortisol,
IL-6, and IL-1β were within the expected limits. The final concentrations for the
biological variables were produced by interpolation from the standard curve in μg/dL for
cortisol and pg/mL for IL-6 and IL-1β.
Psychological measures. The specific psychological measures that were
administered include the Profile of Mood States (POMS) (McNair, Lorr, & Droppleman,
1971), the State-Trait Anxiety Inventory (STAI) (Spielberger, Gorsuch, & Lushene,
1970), the Perceived Stress Scale (PSS) (Cohen, Kamarck, & Mermelstein, 1983) and the
Epworth Sleepiness Scale (ESS) (Johns, 1991).
POMS. The POMS is 65-item self-report assessment that includes six factors,
including confusion, tension, depression, anger, fatigue, and vigor (McNair et al., 1971).
It also includes a composite score of total mood disturbance. McNair et al., (1971) report
that internal consistency ranges from 0.63 to 0.96 whereas test-retest reliabilities range
from 0.65 for vigor and 0.74 for depression, while also noting that it also has strong
criterion-related validity. Subsequent factor analyses, however, suggest that the POMS
may actually tend towards three state dimensions; namely, neuroticism, extraversion, and
arousal (Boyle, 1987). Conversely, evidence derived from a principal components factor
analysis suggests that five, rather than six of the original POMS factors emerge
(Bourgeois, LeUnes, & Myers, 2010). Meaning, the confusion scale did not soundly
emerge as a factor, and interestingly, there was an additional suggested factor that
emerged, namely, mild depression (Bourgeois et al., 2010). There is also short version,
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which includes 37 items (POMS-SV) (Schacham, 1983), as well as the EPOMS, a 30item abbreviated scale (EDITS, 1999). The current study will utilize the original longform, consisting of 65-items (McNair et al., 1971).
STAI. The STAI is a 40-item self-report questionnaire that assesses both state and
trait anxiety, each comprising 20 questions each. This instrument has been widely used in
both research and clinical settings. Spielberger et al., (1983) report that internal
consistency coefficients range from .86 to .95, and that for young adult women, internal
consistency is 0.93 for state anxiety, and 0.92 for trait anxiety. Test-retest reliability
coefficients range from .65 to 0.75. In addition, Spielberger (1989) provides extensive
evidence regarding the measure’s construct and concurrent validity. In terms of content
validity, Julian (2011) reports overall correlations between the STAI and related
measures of anxiety to be 0.73 and 0.85 respectively for the Taylor Manifest Anxiety
Scale (Taylor, 1953) and the Cattell and Scheier’s Anxiety Scale Questionnaire (Krug,
Scheier, & Cattell, 1976).
PSS. The PSS is a 10-item self-report questionnaire that assesses the perception
of stress (Cohen et al., 1983). Lee (2012) reports that it exhibits a Cronbach’s alpha of
0.78 and a test-retest reliability of 0.85 following two days, and 0.55 following six weeks.
Construct validity has been established between the PSS and other measures of stress and
health behaviors (Cohen & Janicki-Deverts, 2012).
ESS. The ESS is an 8-item questionnaire that assesses daytime sleepiness in
adults, such as the propensity to fall asleep while performing activities throughout the
daytime (Johns, 1991). The ESS has been shown to have an internal consistency of 0.71
amongst a sample of 18-25 year olds (Lukowski & Milojevich, 2015), and a test-retest
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reliability of 0.82 (Johns, 1992). Johns (1991) provides evidence of this measure’s
construct validity; in particular, it is capable of detecting changes in sleepiness amongst a
sample of individuals with narcolepsy.
Neurocognitive measures. The neurocognitive measures were all administered
via Joggle Research’s Cognition platform (Joggle Research, Inc., Seattle, WA). The
specific tasks include the psychomotor vigilance task (PVT) (Dinges & Powell, 1985),
the motor praxis task (MP) (Gur et al., 2001), the visual object learning test (VOLT)
(Glahn, Gur, Ragland, Censits, & Gur, 1997), the line orientation test (LOT) (Benton,
Varney, & Hamsher, 1978), the digit symbol substitution task (DSST) (McLeod,
Griffiths, Bigelow, & Yingling, 1982; Wechsler, 1958), the balloon analog risk test
(BART) (Lejeuz et al., 2002), the N-back (Kirchner, 1958), and abstract matching (AM)
(Glahn, Cannon, Gur, & Ragland, 2000).
PVT. The PVT is a measure of reaction time to visual stimuli occurring at random
(Basner & Dinges, 2011). Basner et al., (2015) note that the PVT measures vigilant
attention and is sensitive to the effects of acute and chronic sleep deprivation. Reportedly,
it has negligible practice effects and has been regarded as an externally valid measure of
sustained attention deficits (Basner & Dinges, 2011). The primary brain regions involved
when performing the PVT include the prefrontal cortex, the motor cortex, the inferior
parietal, and portions of the visual cortex (Basner et al., 2015). The Cognition platform
utilizes a 3-minute version of the PVT, which has been documented to have adequate
reliability and validity. Specifically, Basner, Mollicone, and Dinges (2011) report that
intraclass correlation coefficients indicate maximal reliability for the number of PVT
lapses (ICC = 0.888, p < .0001) as well as median response time (ICC = 0.826, p <
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.0001). In terms of validity, the computerized 3-minute PVT paralleled impairments
observed in the 10-minute PVT following sleep restriction, and has been reported to have
good validity (Elmenhorst, Hormann, Oeltze, Pennig, & Vejvoda, 2013).
MP. The MP assesses sensorimotor control and requires that participants click on
an ever-shrinking box that appears on their screen (Neves et al., 2014). The participant is
exposed to 20 boxes, which become increasingly smaller and move locations, and are
thus increasingly difficult to track (Basner et al., 2015). This particular subtest is believed
to incorporate the brain’s sensorimotor cortex (Basner et al., 2015). Swagerman and
colleagues (2016) report a Cronbach’s alpha of 0.93 for accuracy and 0.95 for speed. The
MP has been validated for detecting sex-differences (Roalf et al., 2014), age effects (Gur
et al., 2012), and has been shown to have associations with psychiatric disorders (Neves
et al., 2014).
VOLT. The VOLT is a measure of participants’ memory for complex figures
(Glahn et al., 1997). Participants are presented with a series of 10 complex figures that
they must later correctly identify from a group of 20 figures, some of which include the
previously presented figures. The VOLT is regarded as a measure of spatial learning and
memory, and requires involvement from the medial temporal cortex and hippocampus
(Basner et al., 2015). Glahn et al.’s (1997) initial study indicates that it demonstrates
strong internal consistency of 0.92, and a split-half reliability of 0.906. as well as
convergent validity with the Continuous Visual Memory Task (r = 0.56) and discriminant
validity with the Vocabulary subtest of the Wechsler Adult Intelligence Scale-Revised
(Glahn et al., 1997).
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LOT. The LOT is derived from the widely-used and well validated Judgment of
Line Orientation (JLO) (Benton et al., 1978). Throughout the test, participants are
required to maneuver one line to match another’s orientation; in particular, the test items
vary in difficulty based on the line’s angle, length, and distance from the stationary line
(Basner et al., 2015). The LOT assesses participants’ spatial orientation, which requires
involvement of the right temporo-parietal cortex and visual cortex (Basner et al., 2015).
As indicated, the LOT is derived from the JLO, which is a well-validated measure. In
terms of reliability, Swagerman et al., (2016) report that the LOT exhibits adequate
reliability, with a Cronbach’s alpha of 0.79 for accuracy and 0.97 for speed.
DSST. The DSST is a computerized version of the widely used Wechsler Adult
Intelligence Scale-III’s (WAIS-III) subtest (McLeod et al., 1982). Wechsler (1958)
described the subtest as an assessment of associative learning, and relative to the current
WAIS-V edition, can be best compared to the Coding subtest. The task requires that
participants refer to a displayed legend that refers digits 1-9 to a specific symbol;
importantly, each number has its own specific symbol. Throughout administration, each
number appears in isolation, and the participant is required to match the digit to the
correct symbol as quickly as they can. The DSST is described as a task of complex
scanning and visual tracking and requires the involvement of the temporal cortex,
prefrontal cortex, and motor cortex (Basner et al., 2015). The test-retest correlation
coefficient of the DSST has been reported to be 0.84 (Bittner, Carter, Kennedy,
Harbeson, & Krause, 1986). In terms of concurrent validity, the subtest correlates with
other conventional, computerized neuropsychological tests (e.g., Finger Tapping,
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Switching Attention, and the Continuous Performance Test) by a margin of 0.28-0.40
(Gualtieri & Johnson, 2006).
BART. The BART is a measure of risk-taking behavior (Lejeuz et al., 2002). It
requires that participants either inflate an animated balloon, or conversely, collect a
reward. The reward increases proportionally to how inflated the balloon becomes.
Although, the balloon ‘pops’ following a hidden number of pumps, in which case, the
participant is not rewarded. Participants are therefore required to modulate the extent of
their risk-taking behavior in the form of number of pumps. Basner et al., (2015) report
that risk-taking behaviors implicate the orbital frontal and ventromedial prefrontal cortex,
amygdala, hippocampus, anterior cingulate cortex, and the ventral striatum. White,
Lejeuz, and de Wit (2008) indicate that the BART has strong reliability, such that testretest following sessions was estimated to range from 0.66-0.78. In terms of validity, the
BART has been shown to correlate with several risk-taking behaviors including drug and
alcohol use, gambling, theft, and aggression, in both adolescent and adult populations
(Hunt, Hopko, Bare, Lejeuz, & Robinson, 2005).
N-back. The N-back is a measure of working memory capacity and continuous
performance (Kirchner, 1958). In short, the participant is presented with a series of
stimuli, and they are then asked to denote when the current stimulus matches the one
presented n steps earlier (Kane, Conway, Miura, & Colflesh, 2007). In order to vary the
task’s difficulty, the load factor n can be adjusted. Basner et al., (2015) report that the Nback requires involvement from the dorsolateral prefrontal cortex, the cingulate, and the
hippocampus. In terms of reliability, Kane et al., (2007) report that Cronbach’s alpha
ranges from 0.54-0.84, thus denoting strong reliability. With respect to validity, the N-
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back exhibits convergent validity, although the findings are generally mixed. For
instance, Shelton, Elliot, Hill, Calamia, and Gouvier (2009) found strong convergent
validity between performance on an operation span task and the N-back (r = 0.46),
although its validity as a “pure” working memory has been contested, likely stemming
from the fact that working memory and/or executive functioning are not unitary abilities
(Jaeggi, Buschkuehl, Perrig, & Meier, 2010). More specifically, Jaeggi et al., (2010)
failed to find evidence of convergent validity between the N-back and other measures
(e.g., Reading Span Task) of working memory.
AM. The AM task assesses abstraction and concept formation (Glahn et al.,
2000), and is regarded as a validated test of executive function (Swagerman et al., 2016).
Participants are asked to discern general rules regarding the presented objects’ properties
from specific examples. Specific object properties differ based on perceptual dimensions,
such as shape and color, and participants are asked to sort a target object to one of two
pairs. Sorting is based on implicit, abstracted rules, derived from the different object
properties (Swagerman et al., 2016). Basner et al., (2015) indicate that AM involves the
prefrontal cortex. In terms of validity, Glahn et al., (2000) report that a positive
correlation between performance on an AM task with memory and Digit Span may be
viewed as initial convergent validity, and Basner et al., (2015) report that it is a validated
measure.
Procedures
Participants were initially screened for the preliminary inclusion criteria by means
of a brief telephone interview. Those who met preliminary inclusion criteria and agreed
to be evaluated were scheduled for further screening via a clinical interview. The clinical
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interview began with a review and completion of the informed consent form. The clinical
interview incorporated the MINI, and administration took approximately 15 minutes.
Participants also completed additional measures, including a demographic form, the
PSQI, and the ISI. Following this, participants were given an actigraph, and were
provided with instructions and requirements. Participants were asked to sleep as usual, to
press a button on the actigraph prior to falling asleep and upon waking up (referred to as
an event marker), and to keep the actigraph on their wrist for a total of seven days, and
that it should only be removed when bathing and/or swimming. This period of seven days
was referred to as the baseline week. Throughout the seven days, participants were
instructed that they would receive an email every morning prompting them to complete a
sleep diary, which included questions pertaining to overall well-being, on facets such as
sleep quality and appetite. Finally, a second meeting was scheduled in which participants
would return to the lab seven days later to return the actigraph and await further
instruction. All participant information was coded and stored in a locked cabinet.
Electronic sleep diary data was stored online in a password-protected account.
Procedures for participants representing the Naturally Sleep Restricted
(NSR) group. Based on the preliminary sleep measures collected throughout the baseline
week, participants generally exhibited two of the following: an average sleep time of less
than 7 hours (per actigraphy), and/or ISI score of greater than 8, and/or a PSQI score of
greater than 5. These participants were assigned to the NSR group. Participants returned
to the lab for one testing session, in which the biological, psychological, and
neurocognitive measures were collected. Importantly, this session always took place
between the hours of 4-6pm as a means for controlling for the biological variables’ time-
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of-day effects. In addition, as a means for controlling for the effects of females’ monthly
hormonal fluctuations, the testing session took place during the participants’ luteal phase
of their menstrual cycle, which was ascertained via self-report. Upon completion of this
session, the participants were compensated $35 in the form of a gift card.
Procedures for participants representing the Experimentally Sleep
Restricted (ESR) group. Based on the preliminary sleep measures collected throughout
the baseline week, participants who generally exhibited an average sleep time of greater
than seven hours, and ISI and PSQI scores within normal limits, were assigned to the
ESR group. Participants returned to the lab to initiate their week of sleep restriction. On
day 1, participants’ biological, psychological, and neurocognitive measures were
collected. At the end of the session, participants were given an actigraph, were instructed
to sleep 90 minutes less than their recorded average throughout the initial baseline week,
for a span of 7 days. Similar to the baseline week, participants were asked to refrain from
swimming and bathing while wearing the actigraph, as well as to press the event marker
prior to falling asleep and again when waking up. Participants were also instructed to
respond to the daily sleep diary email that included questions of wellbeing, exercise, and
appetite.
They were further instructed to return to the lab on Days 3, 5, and 7 of the sleep
restriction week. Specifically, on Days 3 and 5, the same biological measures collected at
baseline and Day 1 were collected, whereas on Day 7, the same biological, psychological,
and neurocognitive measures previously collected were again obtained from the
participants. Throughout this week, participants were instructed to refrain from operating
any motor vehicles, consuming caffeine, or napping throughout the course of the day.
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They were also advised that, while in the lab on Days 3 and 5, their actigraphs were
verified as to ensure that the sleep restriction protocol was being adhered to. Importantly,
all data collection sessions over the sleep restriction week took place between the hours
of 4-6pm as a means for controlling for the biological variables’ diurnal fluctuations. In
addition, as a means for controlling for the effects of females’ monthly hormonal
fluctuations, the sleep restriction week took place during the participants’ luteal phase of
their menstrual cycle, which was ascertained via self-report. Following 7 days of sleep
restriction, participants were compensated $75 in gift cards.
Statistical Analyses
Intragroup comparisons. Before conducting the statistical analyses, preliminary
checks on statistical assumptions were verified. In particular, the assumption of normal
distribution was met for some, but not all variables, warranting the inclusion of both
parametric and nonparametric, within-subjects comparisons (Field, 2013). Assumptions
were verified using both graphical and non-graphical approaches.
Research design. In each analysis addressing the within-group comparison
research questions, the independent variable is the time of testing. In the ESR group,
participants completed biological, psychological, and neurocognitive measures on Days 1
and 7 of the sleep restriction week. Thus, the independent variables were these two times
of testing. Biological samples collected on Days 3 and 5 were excluded due to
inconsistencies in specimen collection; meaning, samples were unable to be consistently
obtained on these days due to factors such as scheduling conflicts. The dependent
measures include the biological (i.e., cortisol, IL-6, IL-1β), psychological (i.e., STAI,
ESS, PSS, POMS), and neurocognitive (i.e., all 8 subtests of Joggle Research’s Cognition
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platform) measures. Because the comparisons involve two time points of the same group
of individuals, the repeated-samples t-test will be used. For variables failing to meet the
assumption of normality, the nonparametric equivalent, the Wilcoxon signed-rank test
(Wilcoxon, 1945) was used.
In addition, delta values from Day 1 to Day 7 were computed for all the
biological, psychological, and neurocognitive variables. Following this, delta values for
each variable were correlated; more specifically, delta values for the biological variables
were correlated with the psychological variables, which were correlated with the
neurocognitive variables, in order to ascertain whether deltas in one class of variable (i.e.,
biological, psychological, or neurocognitive) are associated with deltas in another class of
variable. Pearson correlations were conducted for normally distributed variables, and
Spearman correlations (Spearman, 1910) were conducted for non-normally distributed
variables.
Intergroup comparisons. Before conducting the statistical analyses, preliminary
checks on statistical assumptions were verified. In particular, the assumption of normal
distribution was met for some, but not all variables, warranting the inclusion of both
parametric and nonparametric, between-subjects comparisons (Field, 2013).
Assumptions were verified using both graphical and non-graphical approaches.
Research design. In each analysis addressing the between-group comparison
research questions, the independent variable was group membership (i.e., NSR, ESR).
Although there are two groups, two between-group comparisons were tested; specifically,
the NSR group and the ESR group at Day 1, and the NSR group and the ESR group at
Day 7. Testing for NSR and ESR Day 1 comparisons allowed us to determine whether
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the groups differed in terms of their biological, psychological, and neurocognitive
composition in the absence of imposed sleep restriction. Conversely, testing for NSR and
ESR Day 7 comparisons provided additional data, and allowed us to examine whether the
NSR group, which is habitually achieving reduced sleep quantity and/or quality differs
with respect to biological, psychological, and neurocognitive functioning with the ESR
group, which is not habitually achieving reduced sleep quantity and/or quality. The
dependent measures included the biological (i.e., cortisol, IL-6, IL-1β), psychological
(i.e., STAI, ESS, PSS, POMS), and neurocognitive (i.e., all 8 subtests of Joggle
Research’s Cognition platform) measures. Because the comparisons involved two groups
of different individuals, independent samples t-tests were computed, whereas MannWhitney tests (Mann & Whitney, 1947) were computed for analyses including variables
not meeting the assumption of normality.
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Chapter 4: Results
Assumptions
The Shapiro-Wilk test was utilized to verify the assumption of normality, as it is
the recommended analysis when working with smaller sample sizes (Fields, 2013).
Significant values are identified in Table 1, and these indicate that the distribution of
scores deviates from a normal distribution.
Table 1
Shapiro-Wilk Test of Normality (Significant Cases)
Category
Variable
Biological
IL1B_ESR_D1
CORT_NSR
Psychological
STAI-T_ESR_D7
POMS_Tension_ESR_D1
POMS_Tension_NSR
POMS_Depr_ESR_D7
POMS_Confusion_ESR_D1
POMS_Anger_NSR
POMS_TMD_NSR
Neurocognitive

3PVTerr_ESR_D7
3PVTme_ESR_D1
3PVTme_ESR_D7
3PVTme_NSR
BARTme_ESR_D7
NBACKCrMatch_ESR_D7
DSSTcr_NSR
NBACKCrNonMatch_NSR

W
.798
.811
.794
.747
.815
.781
.775
.737
.823

p
.027
.013
.017
.005
.015
.012
.011
.001
.019

.808
.745
.791
.393
.761
.742
.855
.712

.049
.005
.033
.000
.017
.010
.050
.001

Additional indicators of normality, such as skewness and kurtosis were also
examined. Select variables in which skewness or kurtosis were outside the recommended
range are depicted in Table 2. Generally, skewness and kurtosis values ranging from -2 to
+2 are indicative of a normally distributed sample (George & Mallery, 2010). However,
these are highly variable in small samples and hence are often difficult to interpret
(Ullman, 2006). Importantly, variables that exhibited a significant Shapiro-Wilk statistic
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inconsistently evidenced skewness and kurtosis values outside of the recommended
range. Thus, in light of inconsistent evidence to suggest a violation of the normality
assumption, in conjunction with the robustness of parametric tests (Rasch & Guiard,
2004), it was determined that parametric analyses were most appropriate. More
specifically, it has been shown that the “two-sample t-test is so robust that it can be
recommended in nearly all applications,” even when the assumption of normality is
violated (Rasch, Teuscher, & Guiard, 2007, p. 2706).
Table 2
Large Skewness and Kurtosis Values
Category
Variable
Psychological
STAI-S_ESR_D7
POMS_Tension_ESR_D1
POMS_Depr_ESR_D1
POMS_Anger_ESR_D1
POMS_Confusion_ESR_D1
POMS_TMD_ESR_D1
Neurocognitive
MPTme_ESR_D7
BARTme_ESR_D7
NBACKCrMatch_ESR_D7
NBACKRtme_ESR_D1
3PVTme_NSR
LOTme_NSR
BARTbp_NSR
NBACKCrMatch_NSR
NBACKCrNonMatch_NSR
Note. Large values (i.e., >2) are denoted by an asterisk.

Skewness
-2.04*
2.11*
-1.43
0.35
-1.80
-0.34
1.48
1.94
-0.51
1.04
3.28*
1.14
0.19
-1.22
-2.23*

Kurtosis
0.11
4.99*
2.41*
2.65*
3.52*
2.37*
2.40*
3.94*
-2.26*
2.56*
10.91*
2.00*
2.51*
2.71*
5.97*

With respect to the intragroup analyses, homogeneity of variance, and more
specifically, sphericity was assumed as tenable because there was only one set of
difference scores for each research question (Myers & Well, 2003). With respect to the
intergroup analyses, Levene’s Test of Homogeneity of Variance was utilized to ascertain
homogeneity of variance. Violations of this assumption are reported in Table 3.
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Table 3
Group Comparisons: Levene’s Test of Homogeneity of Variance (Non-Tenable Cases)
Comparison
Variable
F
p
1 vs. 2
IL-6
15.235
.001
1 vs. 3
STAI-S
5.333
.033
1 vs. 3
MPTme
5.811
.028
1 vs. 2
Amme
6.986
0.017
1 vs. 3
Amme
5.526
0.032
Note. 1 = Group 1 (NSR); 2 = Group 2 (ESR, Day 1); 3 = Group 3 (ESR, Day 7).

Additionally, steps to identify whether specific data points exerted an undue
influence on a specific variable’s distribution were also computed using regression
diagnostics. This was examined through DFBETAS, which identifies influential
observations by producing a standardized change in test parameters when a given
observation is deleted from the analysis (Rawlings, Pantula, & Dickey, 2001). Six
variables included influential cases beyond the recommended range of greater than
positive two and less than negative two (Belsley, Kuh, & Welsch, 1980); these included
IL-1β, POMS_Depr, POMS_Tension, POMS_Confusion, PSS, STAI-T, and Amcr.
Because the inclusion of the influential cases impacted findings in terms of descriptives
and test statistics, the influential cases were removed from the variables on interest. In
other words, it was determined that removal of the influential case was the appropriate
step in light of the impact it had on subsequent interpretations of findings.
Intragroup Analyses
With regard to the research questions to address within-group differences on
biological, psychological, and neurocognitive measures between Days 1 and 7 of the
sleep restriction week, paired-samples t-tests were used to examine how scores changed
over the course of the week. Because several analyses were conducted, the Bonferroni
correction was utilized to maintain a conservative familywise error rate (Fields, 2013).
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Familywise error was established on the basis of variable class; meaning, the alpha level
was divided by the number of comparisons in the respective biological, psychological,
and neurocognitive classes of variables.
Biological variables. With regard to the biological variables, we hypothesized that
participants would exhibit elevations on their biological markers of health on Day 7 of
the sleep restriction week, relative to Day 1. Results for the effect of sleep restriction
were analyzed using a paired-samples t-test to examine how participants’ levels of
cortisol, IL-6, and IL-1β changed over the course of the week. The means (M) and
standard deviations (SD) for these scores can be found in Table 4. Specific hypothesis
testing results including test statistics (t), significance values (p), and effect sizes
(Cohen’s d) may be found in Table 5.
Table 4
Means and SDs on Pre and Post Sleep Restriction
Time of
Category
Variable
Testing
Biological
Cortisol
1
2
IL-6
1
2
IL-1B
1
2
Note. Time of Testing 1 = ESR Day 1; Time of Testing 2 = ESR Day 7.
Table 5
Pre and Post Sleep Restriction Comparisons
Comparison
n
Cortisol
7
IL-1B
4
IL-6
8

t
.524
-6.39
-1.99

df
6
3
7

M
0.32
0.28
44.14
90.98
30.00
80.10

p
0.62
0.008*
0.09

Note. Comparisons are based on Day 1 and Day 7 results in the ESR group.
*p<0.0167

SD
0.25
0.23
45.70
101.32
23.09
15.32

d
0.23
3.20
0.70
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Hypotheses for the biological variables posited elevations of mean levels of
cortisol, IL-6, and IL-1β as a direct function of sleep restriction. Results indicated a
significant increase in IL-1β following a week of sleep restriction, as well as a large
magnitude of difference between IL-1β prior to and following sleep restriction. Results
did not demonstrate additional significant differences or large effect sizes on measures of
biological health as a function of sleep restriction.
Psychological variables. With regard to the psychological variables, we
hypothesized that participants would exhibit a decrement in their psychological health on
Day 7 of the sleep restriction week, relative to Day 1. Results for the effect of sleep
restriction were analyzed using paired-samples t-tests to examine how participants’ levels
of anxiety (both state and trait), perceived stress, sleepiness, tension, depression, anger,
fatigue, confusion, vigor, and total mood disturbance changed over the course of the
week. The means (M) and standard deviations (SD) for these scores can be found in Table
6. Specific hypothesis testing results including test statistics (t), significance values (p),
and effect sizes (d) may be found in Table 7.
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Table 6
Means and SDs on Pre and Post Sleep Restriction
Category
Variable
Psychological
STAI-S

Time of Testing
1
2
STAI-T
1
2
PSS
1
2
ESS
1
2
POMS_Tension
1
2
POMS_Depr
1
2
POMS_Anger
1
2
POMS_Fatigue
1
2
POMS_Confusion
1
2
POMS_Vigour
1
2
POMS_TMD
1
2
Note. Time of Testing 1 = ESR Day 1; Time of Testing 2 = ESR Day 7.

M
35.44
46.67
35.75
45.88
16.11
18.11
5.78
7.78
1.88
11.63
18.88
4.25
10.44
3.67
5.33
11.56
5.75
8.25
7.22
5.89
33.67
35.00

SD
7.00
10.75
7.57
9.42
5.37
2.76
2.77
4.06
1.96
7.50
4.67
6.74
5.77
4.12
2.92
5.86
1.66
4.06
3.93
3.89
16.96
28.47

Results indicated that participants’ mean level of depression significantly
decreased following a week of sleep restriction, while also exhibiting a large magnitude
of difference prior to and following sleep restriction. Additional large effect sizes were
observed with state anxiety, trait anxiety, tension, anger, and fatigue. More specifically,
there was a large magnitude of difference between pre and post sleep restriction scores
across these variables, such that higher scores were observed following the week of sleep
restriction, with the exception of anger, which was lower following sleep restriction.
Results did not demonstrate additional significant differences or large effect sizes on
measures of psychological health as a function of sleep restriction.
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Table 7
Pre and Post Sleep Restriction Comparisons
n
Comparison
t
df
p
STAI-S
9
-2.73
8
0.03
STAI-T
8
-2.31
7
0.05
PSS
9
-0.88
8
0.40
ESS
9
-2.19
8
0.06
POMS_Tension
8
-4.06
7
0.01
POMS_Depression
8
5.29
7
0.001*
POMS_Anger
9
2.59
8
0.03
POMS_Fatigue
9
-3.22
8
0.01
POMS_Confusion
8
-1.85
7
0.11
POMS_Vigour
9
0.89
8
0.40
POMS_TMD
9
-0.11
8
0.92
Note. Comparisons are based on Day 1 and Day 7 results in the ESR group.
*p<0.0045

d
1.80
0.82
0.29
0.73
1.44
1.87
0.86
1.07
0.66
0.30
0.04

Neurocognitive variables. With regard to the neurocognitive variables, we
hypothesized that participants would exhibit a decrement in their neurocognitive
functioning on Day 7 of the sleep restriction week, relative to Day 1. Results for the
effect of sleep restriction were analyzed using paired-samples t-tests to examine how
participants’ performance on a variety of neurocognitive measures changed in response to
sleep restriction. The neurocognitive measures assessed skills such as vigilant attention,
sensorimotor control, visuo-spatial memory, spatial orientation, processing speed, risktaking behavior, working memory capacity, and abstraction. The means (M) and standard
deviations (SD) for these scores can be found in Table 8. Specific hypothesis testing
results including test statistics (t), significance values (p), and effect sizes (d) may be
found in Table 9. Results did not demonstrate any significantly different mean values on
neurocognitive variables as a function of sleep restriction. Despite this, a large effect size
was found for reaction time on the NBACK subtest, wherein the mean reaction time
following sleep restriction decreased.
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Table 8
Means and SDs on Pre and Post Sleep Restriction
Category
Variable
Neurocognitive
3PVTerr

Time of Testing
1
2
3PVTme
1
2
MPTme
1
2
VOLTcr
1
2
VOLTme
1
2
LOTcr
1
2
LOTme
1
2
DSSTcr
1
2
DSSTme
1
2
BARTbp
1
2
BARTme
1
2
NBACKCrMatch
1
2
NBACKCrNonMatch
1
2
NBACKRtme
1
2
Amcr
1
2
Amme
1
2
Note. Time of Testing 1 = ESR Day 1; Time of Testing 2 = ESR Day 7.

M
3.33
2.57
345.97
364.50
488.79
505.87
16.11
16.14
1739.61
1611.41
12.89
12.43
5941.99
4871.73
87.78
87.86
903.12
905.54
12.56
13.57
558.99
419.01
7.44
9.57
43.67
41.00
590.53
528.70
17.67
16.67
1935.93
1454.44

SD
2.78
3.16
151.76
147.80
75.55
127.29
2.03
3.29
334.82
342.13
2.42
2.15
1432.82
1381.05
10.85
15.32
127.68
195.28
2.65
6.48
323.34
358.20
4.30
1.81
3.24
5.86
76.14
59.32
1.97
1.21
880.62
710.41

65
Table 9
Pre and Post Sleep Restriction Comparisons
Comparison
n
t
3PVTerr
7
1.23
3PVTme
7
0.01
MPTme
7
-0.32
VOLTcr
7
-0.11
VOLTme
7
2.20
LOTcr
7
0.63
LOTme
7
1.67
DSSTcr
7
-0.30
DSSTme
7
0.11
BARTbp
7
-0.53
BARTme
7
1.62
NBACKCrMatch
7
-2.55
NBACKCrNonMatch
7
1.43
NBACKRtme
7
2.04
Amcr
6
1.07
Amme
7
2.24

df
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
6

p
0.27
0.99
0.76
0.92
0.70
0.55
0.15
0.77
0.92
0.61
0.16
0.04
0.20
0.87
0.33
0.07

d
0.19
0.10
0.24
0.01
0.27
0.69
0.60
0.00
0.01
0.15
0.29
0.46
0.52
0.85
0.44
0.43

Note. Comparisons are based on Day 1 and Day 7 results in the ESR group.
*p < 0.003
Intergroup Analyses
With regard to the research questions to address between-group differences on
biological, psychological, and neurocognitive measures, comparisons were drawn
between ESR Day 1 and the NSR group, as well as ESR Day 7 and the NSR group. Two
classes of independent-samples t-tests were conducted in order to compare the NSR
group with the ESR group on Day 1 of the sleep restriction week and to compare the
NSR group with the ESR group on Day 7 of the sleep restriction week. Comparing the
NSR group to the ESR group prior to the sleep restriction manipulation allowed us to
determine whether the groups differed in terms of their biological, psychological, and
neurocognitive composition in the absence of imposed sleep restriction on the ESR
group. Conversely, comparing the NSR group to the ESR group following sleep
restriction (i.e., Day 7) allowed us to also compare the effects of long-standing and
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volitional sleep restriction (i.e., the NSR group) to short-term and non-volitional sleep
restriction (i.e., ESR Day 7) on a variety of health indicators. Because several analyses
were conducted, the Bonferroni correction was utilized to maintain a conservative
familywise error rate (Fields, 2013). Familywise error was established on the basis of
variable class; meaning, the alpha level was divided by the number of comparisons in the
respective biological, psychological, and neurocognitive classes of variables.
Biological variables. With respect to the biological variables, we hypothesized
that the NSR group would exhibit elevations on their biological markers relative to the
ESR group on Day 1 of the sleep restriction week. Meaning, we anticipated that
participants who did not initially report subjective or objective sleep difficulties (ESR) to
exhibit comparatively lower mean levels of cortisol, IL-6, and IL-1β, relative to
participants who were deemed to be naturally sleep restricted. Second, following a week
of sleep restriction, we hypothesized that participants in the ESR group would exhibit
elevations with their biomarkers relative to the NSR group, due to the non-volitional
nature of the manipulation. The means (M) and standard deviations (SD) for these
measures can be found in Table 10. Specific hypothesis testing results including test
statistics (t), significance values (p), and effect sizes (d) may be found in Table 11.
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Table 10
Means and SDs on Based on Group and Time of Testing
Category
Variable
Group
n
M
Biological
Cortisol
1
11
0.22
2
7
0.32
3
7
0.28
IL-6
1
11
107.33
2
8
44.14
3
8
90.98
IL-1B
1
11
62.70
2
6
51.97
3
4
80.10
Note. 1 = Group 1 (NSR); 2 = Group 2 (ESR, Day 1); 3 = Group 3 (ESR Day 7).

SD
0.15
0.25
0.23
96.74
45.70
101.32
54.88
51.73
15.32

Table 11
Group Comparisons on Biological Variables
Variable
Comparison
t
df
p
Cortisol
1 vs. 2
-1.11
16
0.28
1 vs. 3
-0.68
16
0.51
IL-6
1 vs. 2
1.90
15.05
0.08
1 vs. 3
0.36
17
0.73
IL-1B
1 vs. 2
0.39
15
0.70
1 vs. 3
-0.95
12.79
0.36
Note. 1 = Group 1 (NSR); 2 = Group 2 (ESR, Day 1); 3 = Group 3 (ESR, Day 7).
*p < 0.0083

d
0.52
0.27
0.79
0.17
0.20
0.36

Results did not yield any significant between-group differences when comparing
the NSR group to the ESR group on either Day 1 or Day 7 of the sleep restriction week.
Similarly, there were no large effect sizes, although the between-groups comparison
involving the NSR group and ESR group on Day 1 for IL-6 yielded an effect size of 0.79,
just shy of the recommended designation of 0.8 for large effect sizes (Cohen, 1988).
Psychological variables. With respect to the psychological variables, we
hypothesized that the NSR group would exhibit reduced psychological functioning
relative to the ESR group on Day 1 of the sleep restriction week. Meaning, we anticipated
that participants who did not initially exhibit subjective or objective sleep difficulties
(ESR) to exhibit comparatively lower mean levels of anxiety (both state and trait),
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perceived stress, sleepiness, tension, depression, anger, fatigue, confusion, vigor, and
total mood disturbance relative to naturally sleep restricted participants. Second,
following a week of sleep restriction, we hypothesized that participants in the ESR group
would exhibit a greater decrement in psychological functioning relative to the NSR
group, due to the non-volitional nature of the manipulation. The means (M) and standard
deviations (SD) for these measures can be found in Table 12. Specific hypothesis testing
results including test statistics (t), significance values (p), and effect sizes (d) may be
found in Table 13.
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Table 12
Means and SDs on Based on Group and Time of Testing
Category
Variable
Group
n
M
SD
STAI-S
1
11
31.82
7.25
2
9
35.44
7
3
9
46.67
10.75
STAI-T
1
11
34.55
6.83
2
8
35.75
7.57
3
8
45.88
9.42
PSS
1
11
15.09
6.24
2
9
16.11
5.37
3
9
18.11
2.76
ESS
1
11
5.73
2.83
2
9
5.78
2.77
3
9
7.78
4.06
POMS_Tension
1
11
1.27
1.1
2
8
1.88
1.96
3
8
11.63
7.5
POMS_Depr
1
11
13.45
9.95
Psychological
2
8
18.88
4.67
3
6
5.67
7.34
POMS_Anger
1
11
8.64
5.66
2
9
10.44
5.77
3
9
3.67
4.12
POMS_Fatigue
1
11
4.36
3.33
2
9
5.33
2.92
3
9
11.56
5.86
POMS_Confusion
1
11
4.73
3.47
2
8
5.75
1.66
3
8
8.25
4.06
POMS_Vigour
1
11
4.91
3.67
2
9
7.22
3.93
3
9
5.89
3.89
POMS_TMD
1
11
27.55
19.1
2
9
33.67
16.96
3
9
35.00
28.47
Note. 1 = Group 1 (NSR); 2 = Group 2 (ESR, Day 1); 3 = Group 3 (ESR, Day 7).
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Table 13
Group Comparisons on Psychological Variables
Comparison
Variable
t
STAI-S
1 vs. 2
-1.13
1 vs. 3
-3.68
STAI-T
1 vs. 2
-0.36
1 vs. 3
-3.05
PSS
1 vs. 2
-0.39
1 vs. 3
-1.34
ESS
1 vs. 2
-0.40
1 vs. 3
-1.33
POMS_Tension
1 vs. 2
-0.86
1 vs. 3
-3.87
POMS_Depression
1 vs. 2
-1.58
1 vs. 3
1.67
POMS_Anger
1 vs. 2
-0.71
1 vs. 3
2.20
POMS_Fatigue
1 vs. 2
-0.69
1 vs. 3
-3.46
POMS_Confusion
1 vs. 2
-0.91
1 vs. 3
-2.04
POMS_Vigour
1 vs. 2
-1.36
1 vs. 3
-0.58
POMS_TMD
1 vs. 2
-0.75
1 vs. 3
-0.70

df
18
18
17
17
18
18
18
18
17
7.22
15.01
15
18
18
18
18
12.90
17
18
18
18
18

p
0.27
0.002*
0.72
0.01
0.70
0.20
0.97
0.20
0.40
0.01
0.13
0.12
0.49
0.04
0.50
0.003*
0.38
0.06
0.19
0.57
0.46
0.49

d
0.51
1.65
0.17
1.42
0.17
0.60
0.02
0.59
0.40
2.12
0.66
0.85
0.32
0.99
0.31
1.56
0.36
0.95
0.61
0.26
0.34
0.31

Note. 1 = Group 1 (NSR); 2 = Group 2 (ESR, Day 1); 3 = Group 3 (ESR, Day 7).
*p < 0.0023

Results yielded a significant difference between the NSR group and the ESR
group at Day 7 with state anxiety and fatigue. The ESR group exhibited significantly
higher levels of state anxiety and fatigue relative to participants in the NSR group.
Several large effect sizes were also noted, all between the NSR group and the ESR group
at Day 7 of the sleep restriction week. More specifically, there was a large magnitude of
difference between these two groups for state anxiety, trait anxiety, tension, depression,
anger, fatigue, and confusion. Mean levels for all of these with the exception of anger and
depression were higher in the ESR group compared to the NSR group. In other words,
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there was a large effect that revealed higher levels of state anxiety, trait anxiety, tension,
fatigue and confusion in the ESR group compared to the NSR group, and a large effect
that revealed lower levels of depression and anger in the ESR group compared to the
NSR group.
Neurocognitive variables. With respect to the neurocognitive variables, we
hypothesized that the NSR group would exhibit decrements in their neurocognitive
functioning relative to the ESR group on Day 1 of the sleep restriction week. Meaning,
we anticipated that participants who did not initially exhibit subjective or objective sleep
difficulties (ESR) to exhibit greater reductions in performance on tasks requiring vigilant
attention, sensorimotor control, visuo-spatial memory, spatial orientation, processing
speed, risk-taking behavior, working memory, and abstraction relative to naturally sleep
restricted participants. Second, following a week of sleep restriction, we hypothesized
that participants in the ESR group would exhibit a greater decrement in neurocognitive
functioning relative to the NSR group, due to the non-volitional nature of the
manipulation. The means (M) and standard deviations (SD) for these measures can be
found in Tables 14a-14b.
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Table 14a
Means and SDs on Based on Group and Time of Testing
Category
Variable
Group
n
M
SD
3PVTerr
1
11
4.27
3.5
2
9
3.33
2.78
3
7
2.57
3.16
3PVTme
1
11
419.35
509.87
2
9
345.97
151.76
3
7
364.5
147.8
MPTme
1
11
477.19
37.85
2
9
488.79
75.55
3
7
505.87
127.29
VOLTcr
1
11
15.27
2.87
2
9
16.11
2.03
3
7
16.14
3.29
VOLTme
1
11
1731.37
409.04
2
9
1739.61
334.82
3
7
1611.41
342.13
1
11
13.09
2.84
Neurocognitive LOTcr
2
9
12.89
2.42
3
7
12.43
2.15
LOTme
1
11
6806.83
1621.46
2
9
5941.99
1432.82
3
7
4871.73
1381.05
DSSTcr
1
11
83.27
9.23
2
9
87.78
10.85
3
7
87.86
15.32
DSSTme
1
11
959.47
112.97
2
9
903.12
127.68
3
7
905.54
195.28
BARTbp
1
11
11.82
5.36
2
9
12.56
2.65
3
7
13.57
6.48
Note. 1 = Group 1 (NSR); 2 = Group 2 (ESR, Day 1); 3 = Group 3 (ESR, Day 7)
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Table 14b
Means and SDs on Based on Group and Time of Testing
Category
Variable
Group
n
M
BARTme
1
11
544.86
2
9
558.99
3
3
419.01
NBACKCrMatch
1
11
9
2
9
7.44
3
7
9.57
1
11
39.09
Neurocognitive NBACKCrNonMatch
2
9
43.67
3
7
41
NBACKRtme
1
11
578.02
2
9
590.53
3
7
528.7
Amcr
1
11
16.82
2
8
17.63
3
6
16.67
Amme
1
11
1643.13
2
9
1935.93
3
7
1454.44
Note. 1 = Group 1 (NSR); 2 = Group 2 (ESR, Day 1); 3 = Group 3 (ESR, Day 7).

SD
234.64
323.34
358.2
2.93
4.3
1.81
7.04
3.24
5.86
37.3
76.14
59.32
3.19
2.13
1.21
381.36
880.62
710.41

Specific hypothesis testing results including test statistics (t), significance values
(p), and effect sizes (d) may be found in Table 15. While results did not reveal any
significant between-group differences with the NSR and ESR groups on neurocognitive
variables, there was evidence of large effect sizes. First, the NSR group had a higher
mean reaction time on the line orientation task compared to the ESR group following
sleep restriction. Second, the ESR group at Day 1 had a higher mean level of correct nonmatches on the NBACK task compared to the NSR group. Finally, the NSR group
exhibited a higher mean reaction time on the NBACK compared to the ESR group
following sleep restriction. Summary tables illustrating significant and large effect sizes
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for the intragroup comparisons are displayed in Table 16, and those for intergroup
comparisons are displayed in Table 17.
Table 15
Group Comparisons on Neurocognitive Variables
Comparison
Variable
t
3PVTerr
1 vs. 2
0.65
1 vs. 3
1.04
3PVTme
1 vs. 2
0.42
1 vs. 3
0.28
MPTme
1 vs. 2
-0.45
1 vs. 3
-0.71
VOLTcr
1 vs. 2
-0.74
1 vs. 3
-0.59
VOLTme
1 vs. 2
-0.05
1 vs. 3
0.64
LOTcr
1 vs. 2
0.17
1 vs. 3
0.53
LOTme
1 vs. 2
1.25
1 vs. 3
2.61
DSSTcr
1 vs. 2
-1.00
1 vs. 3
-0.80
DSSTme
1 vs. 2
1.05
1 vs. 3
0.75
BARTbp
1 vs. 2
-0.38
1 vs. 3
-0.63
BARTme
1 vs. 2
-0.11
1 vs. 3
0.91
NBACKCrMatch
1 vs. 2
0.96
1 vs. 3
-0.46
NBACKCrNonMatch 1 vs. 2
-1.80
1 vs. 3
-0.60
NBACKRtme
1 vs. 2
-0.48
1 vs. 3
2.18
Amcr
1 vs. 2
-0.62
1 vs. 3
0.11
Amme
1 vs. 2
-0.93
1 vs. 3
0.65

df
18
16
18
16
18
16
18
16
18
16
18
16
18
16
18
16
18
16
18
16
18
16
18
16
18
16
18
16
17
15
10.45
8.24

p
0.52
0.31
0.68
0.79
0.66
0.49
0.47
0.56
0.96
0.53
0.87
0.61
0.23
0.02
0.33
0.44
0.31
0.47
0.71
0.54
0.91
0.38
0.35
0.65
0.09
0.56
0.64
0.05
0.54
0.91
0.37
0.54

d
0.29
0.50
0.19
0.13
0.20
0.34
0.33
0.29
0.02
0.31
0.08
0.25
0.56
1.26
0.45
0.39
0.47
0.35
0.17
0.30
0.05
0.44
0.43
0.22
0.81
0.23
0.22
1.05
0.29
0.06
0.45
0.36

Note. 1 = Group 1 (NSR); 2 = Group 2 (ESR, Day 1); 3 = Group 3 (ESR, Day 7).
*p < 0.0015
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Table 16
Significant and Large Effect Sizes for the Intragroup Comparisons
Comparison
n
t
df
IL1B
4
-6.39
3
STAI-S
9
-2.73
8
STAI-T
8
-2.31
7
POMS_Tension
8
-4.06
7
POMS_Depression
8
5.29
7
POMS_Anger
9
2.59
8
POMS_Fatigue
9
-3.22
8
NBACKRtme
7
2.04
6

p
0.008*
0.03
0.05
0.01
0.001*
0.03
0.01
0.87

d
3.20
1.80
0.82
1.44
1.87
0.86
1.07
0.85

Note. Comparisons are based on Day 1 and Day 7 results in the ESR group.
*p<0.0167 for the biological variables, *p<0.0045 for the psychological variables, and *p
< 0.003 for the neurocognitive variables.

Table 17
Significant and Large Effect Sizes for the Intergroup Comparisons
Variable
Comparison
t
df
p
d
IL-6
1 vs. 2
1.90
15.05
0.08
0.79
STAI-S
1 vs. 3
-3.68
18
0.002*
1.65
STAI-T
1 vs. 3
-3.05
17
0.01
1.42
POMS_Tension
1 vs. 3
-3.87
7.22
0.01
2.12
POMS_Depression
1 vs. 3
1.67
15
0.12
0.85
POMS_Anger
1 vs. 3
2.20
18
0.04
0.99
POMS_Fatigue
1 vs. 3
-3.46
18
0.003*
1.56
POMS_Confusion
1 vs. 3
-2.04
17
0.06
0.95
LOTme
1 vs. 3
2.61
16
0.02
1.26
NBACKCrNonMatch 1 vs. 2
-1.80
18
0.09
0.81
NBACKRtme
1 vs. 3
2.18
16
0.05
1.05
Note. 1 = Group 1 (NSR); 2 = Group 2 (ESR, Day 1); 3 = Group 3 (ESR, Day 7).
*p < 0.0083 for the biological variables, *p < 0.0023 for the psychological variables, and
*p < 0.0015 for the neurocognitive variables.
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Chapter 5: Discussion
In an effort to investigate the impact of sleep restriction, the current study
examined sleep restriction amongst two groups of young women who were either
naturally sleep restricted or experimentally sleep restricted. In doing so, we examined the
impact that sleep restriction has on biological, psychological, and neurocognitive
functioning and whether the impact on functioning differs based on the nature of the
sleep restriction; meaning, is one differentially impacted depending on whether sleep is
restricted in a volitional manner, as in the naturally sleep restricted group, or whether it is
restricted in a non-volitional manner, as in the experimentally sleep restriction group? As
previously noted, the basis for this study derives from numerous gaps in the literature, all
pertaining to an understudied area having a high degree of relevance and ecological
validity in modern society.
Specifically, chronic sleep restriction impacts a significant proportion of the
American population (Luyster et al., 2012), even though the CDC (2014) stipulates that
health and well-being are optimized following a minimum of seven hours of sleep. While
agreement exists as to why there has been a general reduction in number of hours slept,
our ability to answer how this impacts individuals is far from complete, owing to three
primary disagreements in the literature. First, sleep deprivation research is a far more
prolific area of study compared to sleep restriction, and while they both result in fewer
hours of time spent sleeping, it cannot be assumed that their ensuing consequences are
comparable. Second, whether and how individuals’ functioning differs as a result of sleep
restriction, depending on whether it is imposed in a volitional or non-volitional manner,
has yet to be determined. Third, the extent to which sleep restriction affects females is
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unclear, as they have either been excluded from the literature, or if they have been
included, it cannot be assumed that the necessary steps to account for their endogenous
hormonal fluctuation were taken, thereby limiting our ability to extrapolate these
findings.
There is a pressing need to further our understanding, given that women are the
gender most likely to encounter negative health as a result of poor sleep quality, and that
sleep restriction is the sleep paradigm having the greatest ecological validity. As such,
this investigation involved research questions aimed at learning more about sleep
restriction amongst a female sample. In addition, research questions specifically
addressed whether sleep restriction produced alterations in one’s biological,
psychological, and neurocognitive functioning. Finally, the current study also addressed
whether naturally-occurring sleep restriction produced a different constellation of
biological, psychological, and neurocognitive consequences, relative to sleep restriction
that was imposed in an experimental manner.
Pre Versus Post Sleep Restriction Findings
Biological variables. The extent to which IL-1β changes in response to sleep
restriction is not a well understood or studied area within the literature. Our results
demonstrated that following a week of sleep restriction, participants’ mean level of IL-1β
significantly increased, with a large magnitude of effect between IL-1β levels prior to and
following sleep restriction. To our knowledge, this is first study to examine females’ IL1β, while accounting for endogenous hormonal fluctuations, and while also implementing
a sleep restriction manipulation. Existing literature has primarily included a male-only
sample (i.e., Covelli et al., 1992; van Leeuwen et al., 2009), or studies that have included
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females (i.e., Tartar et al., 2015) have not employed a sleep restriction manipulation or
accounted for females’ hormonal fluctuations. Although Tartar et al.’s (2015) research
did not experimentally restrict participants’ sleep, subjective report on amount of time
slept was collected, and participants deemed chronically sleep restricted evidenced
heightened levels of IL-1β relative to participants deemed non-chronically sleep
restricted. Importantly, this sample consisted exclusively of females, thereby supporting
the current study’s findings.
Additional studies examining IL-1β’s relationship to sleep exclusively included a
male sample (i.e., Covelli et al., 1992; van Leeuwen et al., 2009), and employed
divergent manipulations. For instance, Covelli et al. (1992) found that one night of total
sleep deprivation did not result in IL-1β elevations, whereas elevations in IL-1β were
observed in participants that slept normally. However, it should be noted that the sleep
deprivation experienced by the two participants was not a sleep manipulation per se, but
rather the result of being unable to sleep. Thus, their results suggesting no effect of sleep
deprivation on subsequent levels of IL-1β were derived from two participants, neither of
whom slept as a result of non-volitional factors. With respect to van Leeuwen and
colleagues’ (2009) study, sustained marked elevations in IL-1β were found five days
following the end of a prolonged sleep restriction manipulation, raising the possibility
that alterations in IL-1β may be the result of a prolonged duration of shortened sleep, as
was seen in the current study.
Evidently, additional research needs to be conducted in order to ascertain the
extent to which IL-1β levels are impacted following sleep restriction. It should also be
noted that our within-groups comparison only included four participants, and given that
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these may be the first findings to illustrate a rise in IL-1β following sleep restriction in
women, it is imperative that these results be replicated in order to enhance our
understanding of the relationship between IL-1β and sleep. Importantly, as it pertains to
the study of biomarkers, one is able to study differences in mean levels, or one may
choose to examine alterations in secretory patterns. The current study exclusively
examined whether mean levels of the three biomarkers changed in response to sleep
restriction, although we are unable to ascertain whether the sleep restriction manipulation
has any impact on the secretory patterns, including whether the diurnal pattern was
flattened, as has been seen in some studies (i.e., Irwin et al., 2010; Vgontzas et al., 2002).
Therefore, this may be a worthy avenue of further exploration in order to decipher
whether as well as how sleep restriction may be impacting females’ biomarkers.
Finally, in terms of cortisol and IL-6, the current study did not yield a significant
difference in either biomarker following a week of sleep restriction. Like IL-1β, our
understanding of how these are impacted following sleep restriction is far from complete.
For instance, while some studies (i.e., Banks & Dinges, 2007; Omisade et al., 2010)
exhibit elevations in cortisol following sleep restriction, others (i.e., Tartar et al., 2015)
do not. Similarly, with IL-6, some studies illustrate a rise following sleep restriction (i.e.,
Suarez, 2008; Vgontzas et al., 2004), whereas others (i.e., Vgontzas et al., 2002) do not.
As such, additional exploration of these biomarkers would allow our understanding of the
relationship between sleep and biological functioning to be better elucidated.
Psychological variables. Sleep and psychological functioning are intrinsically
tied, with research indicating a link between short sleep duration and reduced
psychological well-being (Mallampalli & Carter, 2014), changes in sleep as a result of
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psychopathology (Basta et al., 2007), and sleep interventions aimed at ameliorating
psychological functioning (Wirz-Justice & Van den Hoofdakker, 1999). In line with
existing research, the current study found that following a week of sleep restriction, the
ESR group exhibited significantly lower levels of depression. Large effect sizes
indicating an increase in state anxiety, trait anxiety, tension, and fatigue were found, in
addition to large effect sizes demonstrating a reduction in depression and anger. Contrary
to the literature, no significant differences or large effect sizes were found for perceived
stress, sleepiness, confusion, vigor, and total mood disturbance.
The significant decrease in depression following a week of sleep restriction aligns
with the induced-wakefulness therapy intervention, which posits a reduction in
depressive symptomatology following sleep deprivation and partial sleep deprivation
(Hemmeter et al., 2010). However, induced-wakefulness therapy has been shown to lead
to reductions in depression amongst clinical samples (Hemmeter et al., 2010), and that
diminishing a non-clinical sample’s sleep usually leads to diminished positive affect
(Wirz-Justice & Van den Hoofdakker, 1999). Our findings are intriguing given that the
ESR group is a non-clinical group, as determined by their responses to a structured
clinical interview at the current study’s outset. This result is even more compelling when
viewed in conjunction with the additional large effect sizes; more specifically, increases
in state and trait anxiety, tension and fatigue, as well as a reduction in anger.
The overlap in depression and anxiety throughout the literature is well
established, yet the current findings suggest a negative trend between these two
constructs. What may possibly account for these findings? Hirschfeld (2001) indicates
that approximately 50% of patients presenting with an anxiety or depressive disorder
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present with a comorbid secondary anxiety or depressive disorder. Further, patients with
anxiety and depression present with sleep complaints at a higher frequency than patients
without anxiety and depression (Basta et al., 2007; Hirschfeld, 2001). However, sleep
deprivation results in alleviation of depressive symptoms and not anxiety symptoms
(Wirz-Justice & Van den Hoofdakker, 1999), thereby drawing a distinction between the
two constructs as they pertain to sleep loss. Taken together, what mechanism may be at
play that would warrant a decrease in depression yet an increase in anxiety? Additionally,
why would a non-clinical sample be evidencing reductions in depressive
symptomatology?
Induced-wakefulness therapy has been implicated in the reduction of depression
when implemented in a total or partial sleep deprivation paradigm (Hemmeter et al.,
2010) – the latter also constituting a sleep restriction paradigm. An overlap in
neurotransmitter system, circadian rhythms, and mood state regulation specifically
involving serotonin is believed to underscore the mechanism of action (Wirz-Justice &
Van den Hoofdakker, 1999). In particular, total sleep deprivation increases the turnover
of serotonin (Hemmeter et al., 2010), and also, “a functional polymorphism within the
promoter of the 5HT transporter gene is associated with a better response to fluvoxamine
and paroxetine… is also associated with a better mood amelioration after sleep
deprivation” (Wirz-Justice & Van den Hoofdakker, 1999, p. 448). Meaning, individual
differences in clinical response to selective-serotonin reuptake inhibitor therapy predicts
whether mood is improved following sleep deprivation, further highlighting the link
between sleep, depression, and serotonin. Finally, it has also been hypothesized that

82
altered serotonergic activity results from immune dysfunction, including immune
responses (Dinges, Douglas, Hamarman, Zaugg, & Kapoor, 1995).
Taken together, there is reason to believe that serotonin plays an instrumental role
in explicating the alleviation of depressive symptoms following a week, yet this effect is
traditionally observed among clinical samples, whereas the reverse holds true with nonclinical samples. This raises the possibility that the short-term nature of inducedwakefulness therapy constitutes one of the mechanisms leading to a reduction in
depressive symptomatology, which according to the current findings, may be observed in
both clinical and non-clinical samples. In other words, although induced-wakefulness
therapy has typically been regarded in terms of its clinical significance for depressed
individuals, the current results demonstrate statistical significance for non-depressed
individuals. In addition, it may also be postulated that the increased availability of
circulating serotonin not only accounts for a reduction in depressive symptomatology, but
also a reduction in negative affect – a mood characteristic observed in both clinical and
non-clinical samples. Thus, even though induced-wakefulness therapy has been regarded
as a treatment in the alleviation of depression among clinical samples, it may be that this
effect is also observed among non-clinical samples, but given the reduced relevance for
non-clinical samples, it may be that this effect has been overlooked in the literature.
In addition to a reduction in depression, the current study exhibited a large
magnitude of effect for the decrease of anger prior to and following sleep restriction. We
suspect that the observed reduction in anger is related to the observed reduction in
depression. Meaning, depression has frequently been conceptualized as a form of selfdirected anger (Sahu, Gupta, & Chatterjee, 2014), and favorable responses to induced-
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wakefulness therapies include positive effects on thought content, including the reduction
of negative cognitions (Hemmeter et al., 2010). In addition, positive associations between
depression and anger have been found, but only for anger that was suppressed, rather than
expressed (Sahu et al., 2014). Moreover, a large effect size was found for an increase in
fatigue, and viewed in conjunction with the decrease in anger, it may be possible that the
heightened fatigue muted participants’ anger (Hatfield et al., 2002). However, recent
evidence (i.e., Krizan & Hisler, 2018) suggests that sleep loss leads to a reduction in
one’s ability to inhibit their anger; meaning, sleep loss may actually increase anger. Yet,
this finding implicates neurocognitive functioning as a mediating factor, rather than sleep
restriction as a causal factor, which still leaves us with unanswered questions. For
instance, in the absence of changes in one’s ability to inhibit their anger, is anger
impacted following sleep restriction?
Finally, large effect sizes denoting an increase in state and trait anxiety were
found, and these effects largely mirror the documented increase in anxiety following
sleep loss (i.e., Dinges et al., 1997; Hemmeter et al., 2010; Kahn et al., 2010; Minkel et
al., 2012; Tartar et al., 2015). Like anger, it has been hypothesized that anxiety increases
following sleep loss as a result of one’s diminished ability to regulate emotions (Baum et
al., 2014; Minkel et al., 2012), whereas other research (i.e., Tartar et al., 2015) directly
ascribe the increase in anxiety to sleep loss. Although depressive symptomatology, like
anxiety, is said to increase following sleep restriction among non-clinical samples,
induced wakefulness paradigms have been shown to specifically alleviate depression and
not anxiety (Wirz-Justice & Van den Hoofdakker, 1999), again drawing a distinction
between the two as they pertain to sleep loss. While both sleep restriction and induced
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wakefulness paradigms require a restriction of the individual’s time spent sleeping, sleep
restriction is typically implemented in a non-volitional manner whereas induced
wakefulness paradigms are implemented in a volitional fashion with the goal of
alleviating depressive symptoms. Further, due to the high degree of overlap in content
validity between tension and anxiety, we believe that these represent the same, rather
than different effects. More specifically, the tension subscale on the POMS has been
operationalized as to include “feelings such as nervousness, apprehension, worry, and
anxiety.” (Terry et al., 2003, p. 131). As such, we believe that the observed increase in
tension may be accounted for by the concomitant increase in anxiety.
In their study examining anxiety and depression in response to sleep restriction,
Baum and colleagues (2014) found that participants were increasingly “on edge”,
nervous, and restless following sleep restriction but they did not exhibit elevated
depression. They attributed this finding to the participants’ ages, which ranged from 1417, and suggested that depressive symptoms manifest as irritability rather than depression
within this age group. Given that the current study included a similarly-aged sample of
young women, is it possible that the reduction in depression and increase in anxiety and
tension reflect this age-related trend? Or rather, are Baum and colleagues’ (2014)
findings also an indication that anxiety and depression may be differentially affected by
short-term sleep restriction, with younger individuals exhibiting a greater propensity to
develop anxiety as opposed to depressive-related symptoms?
In all, our results demonstrated significant effects and large effect sizes following
sleep restriction with some psychological indices, but not with others. While this is to be
expected, there is a high degree of overlap in some of the psychological constructs we
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assessed, and it is curious that large effects were observed for some and not others. For
instance, perceived stress did not exhibit a large effect size, whereas state and trait
anxiety as well as tension did. It is interesting and unlikely that the participants exhibited
elevated tension and anxiety in absence of elevated stress. An additional possible
discrepancy entails the large effect found for fatigue but not for sleepiness. It is suspect
that participants endorsed tension and anxiety and fatigue in the absence of large effect
sizes for perceived stress and sleepiness. Rather, is it conceivable that these psychological
constructs lack adequate criterion validity across the measures? If so, this certainly
constitutes one of the limitations in the assessment of the psychological variables, and we
encourage that additional psychometric research be conducted in validating these
instruments predictive and concurrent validity. Further, and equally important, is the
extent to which these instruments are able to confer ecological validity within the context
of sleep research, and this too should constitute an area warranting additional validation.
Neurocognitive variables. With respect to the neurocognitive variables, we did
not find any significant differences, but we did find one large effect size. More
specifically, the large effect denotes a decrease in reaction time on the NBACK, although
this finding is not in line with existing research (Belenky et al., 2003; Dinges et al., 1997;
Stenuit & Kerkhofs, 2008). Thus, none of our hypotheses and research questions
examining neurocognitive functioning within the ESR group following sleep restriction
were supported. This is generally contrary to what the literature suggests, as sleep loss
has been associated with decrements in working memory, divided attention, inhibition,
verbal fluency, problem solving, increased reaction time, mental arithmetic, language,
and social cognition (Martin et al., 1996; Pilcher et al., 2007; Stenuit & Kerkhofs, 2008).
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The decrease in reaction time on the NBACK runs contrary to the literature,
which suggests that sleep restriction results in increased reaction time (Belenky et al.,
2003; Dinges et al., 1997; Martin et al., 1996; Stenuit & Kerkhofs, 2008). What is
especially surprising about this finding is that out of any neurocognitive variables,
increases in reaction time following sleep loss are said to be the most reliable finding
(Stenuit & Kerkhofs). An additional observation is that even though reaction time
decreased following sleep restriction, no meaningful difference in number of errors made
was found, negating the possibility that the decreased reaction time could be attributed to
decrements in inhibition. While one may suspect a practice effect, it is unusual that it
would discriminatively impact the NBACK’s reaction time without any impact across the
other variables. It may be that participants had difficulty comprehending the task or
lacked motivation to engage with it compared to their first exposure to the task. If so, this
would constitute one of the biggest limitations inherent in the neurocognitive measures.
While we suspect that participants generally comprehended the tasks, relative to
completion of the psychological measures for instance, they asked for clarification at a
higher rate, inviting the possibility that they found some of the subtests harder to
maneuver. Despite this, we do not believe that this invalidates the test, rather, they should
be regarded with caution.
Experimental Versus Natural Sleep Restriction Findings
In order to examine whether NSR participants differ in terms of their biological,
psychological, and neurocognitive functioning, they were compared with the ESR group.
As stated, the ESR group did not exhibit any subjective or objective indicators of
pathological sleep, whereas the NSR group did, and consisted of participants exhibiting
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reduced sleep quality as determined by subjective report and objective measures.
Therefore, in comparing the NSR group to the ESR group we sought to establish whether
the NSR group exhibited a unique constellation of biological, psychological, and
neurocognitive indices suggestive of poor sleep. More specifically, in comparing the
NSR group to the ESR group at Day 1, we examined whether the two groups differed
across classes of variables prior to any sleep restriction taking place. Meaning, in light of
the NSR group’s prolonged pattern of short sleep duration, we sought to examine whether
participants in the NSR group exhibited a decrement in biological, psychological, and
neurocognitive functioning relative to the ESR group. Further, we also compared the
NSR group to the ESR group at Day 7, allowing us to ascertain whether the groups’
functioning differed depending on whether the sleep restriction was implemented in a
volitional manner. In other words, does the non-volitional nature of the sleep restriction
manipulation lead to poorer biological, psychological, and neurocognitive outcomes for
the ESR group at Day 7?
Biological variables. Although our analyses did not reveal any significant
findings, a large effect size was found for IL-6 between the NSR group and ESR group at
Day 1. More specifically, there was a large magnitude of difference in mean levels of IL6, such that the NSR group exhibited higher mean levels of IL-6, relative to the ESR
group at Day 1. These findings generally fit within the context of existing literature,
which suggests that sleep restriction leads to an increase in IL-6 (i.e., Irwin et al., 2010;
Smith et al., 2019; Suarez, 2008; van Leeuwen et al., 2009; Vgontzas et al., 2002;
Vgontzas et al., 2004), although some studies (i.e., Lekander et al, 2013; Shearer et al.,
2001) do not suggest an increase. Interestingly, Lekander and colleagues’ (2013) and
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Shearer and colleagues’ (2001) studies exclusively included males, raising the possibility
that men and women’s IL-6 may be differentially impacted in the face of sleep loss.
Similarly, both studies questioned whether IL-6 did not increase due to either an effect of
gender, or possibly that the sleep restriction did not take place for an extended enough
amount of time (Lekander et al., 2013; Shearer et al., 2001).
Given that our findings demonstrate elevated IL-6 amongst a sample of
participants deemed naturally sleep restricted, it is conceivable that routinely achieving
fewer than seven hours of sleep has greater power in eliciting elevations in IL-6
compared to shorter-term manipulations. Additional evidence of this derives from
Vgontzas et al.’s (2002) study wherein participants routinely achieving fewer than 6.5
hours of sleep at least four times per week for a period of at least six months evidenced
altered IL-6 diurnal rhythms. More specifically, they found that the sleep restricted
participants’ IL-6 peaked earlier in the evening relative to the controls. Given that the
current study collected biological samples in the early evening, it raises the possibility of
whether we captured this earlier IL-6 peak time within the naturally sleep restricted
group. However, it also cannot be assumed that prolonged sleep restriction is solely
responsible for elevations in IL-6, as numerous studies have also captured elevations in
IL-6 following shorter-term paradigms (i.e, Irwin et al., 2010; Suarez, 2008; van
Leeuwen et al., 2009; Vgontzas et al., 2004).
Psychological variables. Several large effect sizes between the NSR group and
the ESR group at Day 7 were uncovered, in addition to one statistically significant
finding. More specifically, the ESR group at Day 7 exhibited significantly greater fatigue
compared to the NSR group. Large effect sizes were found suggesting elevated state
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anxiety, trait anxiety, tension, fatigue, and confusion in the ESR group at Day 7 relative
to the NSR group. Finally, the NSR group exhibited greater levels of depression and
anger relative to the ESR group at Day 7. Contrary to the literature, no significant
findings or large effect sizes were found for perceived stress, sleepiness, vigor, and total
mood disturbance.
Beginning with the findings that denote increased anxiety, tension, fatigue, and
confusion in the ESR group at Day 7 relative to the NSR group, we believe that the nonvolitional nature of the sleep restriction manipulation elicited these characteristics at a
greater propensity in the ESR group. To reiterate, the ESR group is the group, prior to
sleep restriction, that exhibited non-pathological sleep characteristics and an average
sleep time between seven to nine hours. Per Tartar and colleagues’ (2015) findings, they
examined volitional sleep restriction and found that this form of sleep restriction is
associated with increased depressive symptomatology, findings that are consistent with
the literature. However, relative to the current study’s findings, we did not identify
between group differences with the NSR and ESR group at Day 1, but rather, large
magnitudes of differences emerged at Day 7 of the ESR’s sleep restriction week. More
specifically, prior to any sleep restriction, the NSR and ESR groups did not differ with
respect to their psychological functioning, but rather, a decrease in depression and anger
was seen among ESR participants at Day 7, with a concomitant increase in anxiety,
tension, fatigue, and confusion - a group difference attributable to the sleep manipulation
and not pre-existing differences. Thus, the lack of difference in the NSR and ESR group
at Day 1 with respect to psychological functioning stands in contrast with existing
literature (i.e., Tartar et al., 2015), possibly owing to the length of the participants’ sleep
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restriction, which spanned the course of one month in Tartar and colleagues’ (2015)
study. Given that the current study includes the addition of a group undergoing nonvolitional sleep restriction, we also add to the literature in illustrating a delineation of
psychological effects depending on whether sleep is restricted in a volitional versus nonvolitional manner. More specifically, the current data suggest that the ESR group is more
vulnerable to the effects of short-term and non-volitional sleep restriction than the NSR
group is to long-term and volitional sleep restriction in terms of anxiety, tension, fatigue,
and confusion.
With respect to the heightened depression and anger observed in the NSR group
relative to the ESR group at Day 7, we postulate that these effects are the result of the
ESR group exhibiting a decline in depression and anger. It should be noted that this
finding exhibited a large magnitude of difference only when comparing the NSR group to
the ESR group at Day 7 – not at Day 1. Meaning, there was no meaningful difference in
the NSR and ESR group at Day 1, suggesting that the NSR and ESR group do not
fundamentally differ with respect to their levels of depression and anger, but rather, they
only differ after the ESR group underwent sleep restriction. It is conceivable that these
findings are accounted for by the fact that the ESR group at Day 7 is exhibiting reduced
depression and anger as a result of their short-term participation in a sleep restriction
paradigm, a trend documented within induced wakefulness therapy (Hemmeter et al.,
2010; Wirz-Justice & Van den Hoofdakker, 1999). Otherwise, our results do not suggest
a between-groups difference in depression and anger prior to sleep restriction in the ESR
group and the NSR group.
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As indicated, the link between sleep loss and reduced psychological functioning is
well established within the literature, although our results provide a comparison of how
psychological health is differentially affected depending on the nature of the sleep
restriction. Whereas some studies have supported the degradation of psychological health
following short-term and non-volitional manipulations (i.e., Baum et al., 2014; Dinges et
al., 1997; Haack & Mullington, 2005; Minkel et al., 2012), others have demonstrated
effects following long-term and volitional patterns (i.e., Bower et al., 2010; Steptoe et al.,
2008; Tartar et al., 2015). Given that our study has evaluated effects across both
paradigms, we add to the literature through establishing which paradigm is associated
with particular psychological changes. Evidently, the NSR group is better able to mitigate
the negative consequences of sleep restriction relative to the ESR group as this pertains to
psychological health. Although the NSR group and the ESR group (during sleep
restriction) slept a comparable amount, the NSR group’s enhanced functioning relative to
the ESR group likely reflect their habituation with the reduced number of hours slept,
having further implications with how the sleep restriction is perceived. Meaning, it has
been shown that those who are chronically sleep restricted may lack a general awareness
of how deleterious this may be, thereby minimizing its perceived impact on one’s
psychological functioning (Alhola & Polo-Kantola, 2007).
Of note, is that our results for the ESR group are based on two times of testing
whereas our results for the NSR group are based on one time of testing. Although this
was the case for the biological measures, assessing psychological functioning is
complicated by the fact that participants’ responses entail a degree of bias and/or
subjectivity. What may also impact responses to psychological assessments are demand
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characteristics, and while we do not suspect that this took place, it may be possible that
the participants, after becoming more acquainted with the experimenters, felt less
inclined to endorse certain items for fear of eliciting a negative response from the
experimenter. Conversely, it may be that the participants wanted to provide responses
that they perceived to be in line with the study’s hypotheses. Given that the participants
in the ESR group met with the experimenters on numerous occasions, relative to
participants in the NSR group, it may be that the increased exposure to the experimenters
had the potential to elicit a higher likelihood of answering psychological instruments in a
biased fashion. However, it also possible that this increased contact and rapport led the
participants in the ESR group to respond in a more honest fashion.
Neurocognitive variables. Although no significant findings emerged, there were
three large effect sizes. First, the NSR group exhibited a higher mean reaction time on the
LOT compared to the ESR group at Day 7, which runs contrary to our hypothesis.
Second, the ESR group at Day 1 exhibited more correct non-matches on the NBACK
compared to the NSR group, which supports our hypothesis. Third, the NSR group
exhibited a higher mean reaction time on the NBACK relative to the ESR group at Day 7,
and this also runs counter to our hypothesis. In addition, hypotheses suggesting stronger
neurocognitive performance in the ESR group at Day 1 compared to the NSR group and
stronger performance in the NSR group compared to the ESR group at Day 7 were not
supported.
Like our intragroup finding demonstrating a reduced reaction time on the
NBACK following sleep restriction, we see that the NSR group’s reaction time is
elevated compared to the ESR group at Day 7. While this may be interpreted to mean that
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prolonged and volitional sleep restriction elicits greater reaction times on a working
memory test relative to non-volitional sleep restriction, there is no evidence to suggest
that non-volitionally restricting one’s sleep leads to improved reaction time, rather, this
contradicts the most well-regarded impact of sleep restriction on neurocognitive
functioning; namely, increased reaction time (Belenky et al., 2003; Dinges et al., 1997;
Martin et al., 1996; Stenuit & Kerkhofs, 2008). Similarly, the higher mean reaction time
observed in the LOT for NSR participants relative to ESR participants at Day 7 is
unlikely an accurate representation of improved performance on a visuo-spatial task for
non-volitionally sleep restricted participants. Rather, we believe that the mechanism
driving this effect relates to a reduction in motivation on the ESR participants at Day 7.
More specifically, Cohen-Zion and colleagues (2016) illustrated that sleep satiety
underscores optimal performance on tasks requiring heightened motivation, thereby
having consequences in terms of how the task is approached. Thus, in the absence of
sleep satiety, the ESR participants likely lacked the necessary initiative to approach the
task in an effortful way, and although this translates into a reduced reaction time, this was
not accompanied by an increase in number of correctly answered items. Thus, we believe
these two effects should be interpreted with caution and that the results are the likely
representation of reduced motivation. Importantly, we believe that reduced motivation
factored into participants’ performance across all subtests (following sleep restriction),
yet only contributed to large magnitude of effects within discrete subtests, possibly owing
to these subtests’ complexity. In other words, perhaps a greater amount of motivation is
required on the NBACK and LOT and the sleep restriction manipulation etched away at
the required motivation and initiative required to successfully maneuver them.
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With respect to the greater number of correct non-matches on the NBACK seen
within the ESR group at Day 1 relative to the NSR group, we see support for our original
hypothesis purporting stronger neurocognitive performance in the ESR group at Day 1
compared to the NSR group. Given that the NBACK is a working memory and
continuous performance measure, it raises the possibility that prolonged and volitional
sleep loss results in reduced performance. Although this finding is in line with existing
research (i.e., Van Dongen et al., 2003), we are hesitant to put too much weight in this
finding. In particular, out of all of our intra and intergroup neurocognitive analyses, this
was the only one in line with our original research questions. Given that other
neurocognitive deficits (such as increased reaction time) more reliably follow sleep
restriction than correct number of non-matches, and that we failed to find any other
significant effects or large effect sizes in line with our hypotheses, we suspect that the
Joggle Research platform lacked sensitivity in detecting changes as a result of sleep
restriction. Again, this constitutes one primary limitation within the design of the current
study, and we would encourage future research to either supplement these neurocognitive
measures with additional ones, or conversely to utilize a different platform altogether.
General Discussion
In synthesizing the intra and intergroup findings, we are able to examine from a
holistic perspective how each class of variable responded to sleep restriction that was
either volitional or non-volitional. Beginning with the biological variables, we first found
a significant increase in IL-1β following a week of sleep restriction, as well as a large
effect size. An additional large effect size was found between the NSR group and ESR
group at Day 1 in terms of IL-6. Although both of these findings are in line with our
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original hypotheses, these findings also raise interesting questions. Per our findings, it
appears as though IL-1β is responsive to a non-volitional and short-term sleep restriction
manipulation, whereas IL-6 was not. Rather, IL-6 was shown to have a large magnitude
of difference amongst the NSR group and the ESR group at Day 1. Taken together, it
stands to reason that IL-1β and IL-6 are differentially impacted depending on the nature
of the sleep manipulation. More specifically, Smith et al., (2019) highlight that “unlike
IL-1β, IL-6 is not a direct somnogenic factor, but sleep loss results in increased IL-6
levels (p.2).” Meaning, whereas IL-1β administration results in sleep and fatigue, sleep
loss itself has been identified as a precursor to elevated IL-6. Thus, it is likely that the
increase in IL-1β seen within the ESR group accounts for the enhanced fatigue also seen
within this group. The absence of IL-1β elevations within the NSR group with the
concomitant absence of fatigue also illustrates that the two inflammatory markers
respond differently on the basis of type of sleep loss.
In studies (i.e., Lekander et al., 2013; Shearer et al., 2001) examining IL-6 in
response to sleep restriction that did not result in elevations, the authors posited that this
may have related to gender or the chronicity of the sleep restriction. In other words, both
studies only included males, and one required that participants restrict their sleep to four
hours per night for a period of five nights (Lekander et al., 2013), whereas the other study
required that participants restrict their sleep to a period of two hours per day for four days
(Shearer et al., 2001). In the current study, participants were asked to restrict their sleep
for a seven-day period, which did not subsequently lead to an increase in IL-6. Although,
participants deemed naturally sleep restricted exhibited elevations in IL-6 relative to
participants who did not exhibit sleep restriction. Therefore, our finding may highlight
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that prolonged and volitional sleep restriction exudes a greater increase in IL-6, rather
than short-term and non-volitional sleep restriction.
With respect to IL-1β, the increase following sleep restriction mirrors a suspected
inverse relationship between shortened sleep duration and increases in circulating IL-1β
(Covelli et al., 1992; van Leeuwen et al., 2009). Although, these results only hold for our
ESR group, in that the NSR group did not exhibit elevated IL-1β relative to the ESR
group at Day 1. In other words, our study’s short-term and non-volitional sleep restriction
manipulation resulted in IL-1β elevations, but these were not observed amongst naturally
sleep restricted participants. These results stand in contrast with Tartar and colleagues
(2015) who demonstrated that self-reported volitional sleep restriction over the previous
month results in increased IL-1β. Thus, the extent to which volitional versus nonvolitional sleep restriction affects levels of IL-1β remains unclear; however, what may
account for the rise in IL-1β across both studies relates to a possible delay in melatonin
onset (Rogers & Dinges, 2008). Meaning, delaying one’s sleep onset time as a result of
the sleep restriction manipulation likely entailed prolonged exposure to bright lights (in
an attempt to stay awake), thereby delaying melatonin onset, and melatonin itself is
responsible for the secretion of IL-1β in human peripheral mononuclear cells (Tartar et
al., 2015). In particular, melatonin attenuates IL-1β (Favero, Franceschetti, Bonomini,
Rosella, & Rezzani, 2017), but following sleep restriction, the current study illustrated a
rise in IL-1β, therefore raising the possibility that a delayed sleep-onset time reduces
melatonin’s impact in tapering IL-1β.
Like the biological variables, the psychological variables exhibited interesting
patterns within and between subjects. As indicated, following a week of sleep restriction,
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the ESR group exhibited large effect sizes denoting an increase in state anxiety, trait
anxiety, tension, and fatigue. There was also a significant difference in depression,
indicating a decrease following sleep restriction with a comparable large effect size.
Further, a large effect size indicating a decrease in anger following sleep restriction was
also found. With respect to the between-groups comparisons, the ESR group at Day 7
exhibited elevated state and trait anxiety, tension, fatigue, and confusion. Additionally,
relative to the ESR group at Day 7, the NSR group exhibited elevated depression and
anger.
Viewing the biological and psychological findings in conjunction, the increase in
IL-1β was accompanied by an increase in anxiety, tension, and fatigue and a decrease in
depression and anger following a week of sleep restriction. IL-6 was elevated in the NSR
group relative to the ESR group at Day 1, making this the only large effect involving the
NSR group and the ESR group at Day 1. The remaining large effects in terms of the
psychological variables were found for the NSR group and the ESR group at Day 7, and
included elevated state anxiety, trait anxiety, tension, and fatigue and reduced depression
and anger in the ESR group at Day 7. Meaning, the NSR and ESR group (prior to sleep
restriction) did not differ with respect to psychological functioning. Although the NSR
group exhibited reduced sleep quantity and quality, they did not exhibit reduced
psychological functioning compared to the ESR group at Day 1. Importantly, the only
large between-groups effects are driven by the decrements in psychological health
observed within the ESR group following sleep restriction. While these results stand in
contrast with some research suggesting a decrement in functioning following long-term
sleep restriction (i.e. Bower et al., 2010; Suarez, 2008; Tartar et al., 2015), it supports
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other research indicating that there are between-group differences in the amount of sleep
needed in order to achieve optimal functioning (i.e. Banks & Dinges, 2007). Evidently,
the NSR and ESR groups fundamentally differ with respect to their ability to weather the
negative psychological consequences associated with sleep restriction.
As indicated, the non-volitional component, as well as the fact that the restricted
sleep runs contrary to their homeostatic sleep needs is the likely effect eliciting reduced
functioning in terms of anxiety, tension, fatigue, and confusion. Interestingly, confusion
did not increase over the ESR group’s sleep restriction week, but rather it only emerged
as a large effect between the NSR and the ESR group at Day 7, further highlighting how
the routinized nature of the NSR group’s restricted sleep allowed this group to better
withstand these effects. Per Banks and Dinges (2007), not everyone is affected by sleep
limited to less than seven hours per day in the same fashion; for instance, some
individuals “experience very severe impairments even with modest sleep restriction
versus those who show few if any neurobehavioral deficits…” (p. 524). Given that the
current study initially categorized participants on the basis of reported and observed
indicators of sleep quality and that they were differentially impacted when encountering
comparable amounts of sleep, our findings support those of Banks and Dinges (2007)
which highlight “trait-like” differences in neurobehavioral response to sleep loss. This
suggests that the NSR group may have included participants who, relative to the ESR
group, required fewer hours of sleep in order to maintain adequate functioning. While the
non-volitional component of the ESR group’s sleep restriction likely accounted for the
decrement in psychological functioning, it is also conceivable that trait-like differences
allowed the NSR group to maintain adequate psychological functioning (Banks &
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Dinges, 2007; Van Dongen, Baynard, Maislin, & Dinges, 2004). Meaning,
interindividual differences in the ability to withstand the deleterious effects of sleep loss
may have served as a protective factor in mitigating a reduction in functioning among the
NSR participants.
Our results support the notion that sleep loss elicits divergent effects on
psychological functioning that are dependent upon interindividual differences. While
Banks and Dinges (2007) further posit that “the biological bases of differential responses
to sleep loss are not known,” (p.524), we suspect that a comparable mechanism is at play.
Meaning, the trait-like differences in response to sleep restriction may extend beyond
psychological variables and implicate biological variables such as pro-inflammatory
cytokines. More specifically, short-term sleep restriction appears to increase activity of
the sympathetic nervous system, thereby increasing inflammatory responses (Irwin &
Cole, 2011). The non-volitional nature of the ESR group’s sleep manipulation constituted
a psychological and physiological stressor, thereby having the potential to elicit increased
activity of the sympathetic nervous system and inflammation. However, only an increase
in IL-1β, not IL-6, was noted. Our results suggest that IL-1β, rather than IL-6, may be
more responsive to sleep restriction under non-volitional circumstances. Our results also
indicate that increased IL-1β (and not Il-6) is accompanied by a concomitant increase in
anxiety, tension, and fatigue and a decrease in depression and anger, raising the
possibility that biological and psychological health interact synergistically.
Interestingly, no significant differences between the NSR and ESR group at Day 7
emerged for IL-6, but only between the NSR group and ESR group at Day 1. This signals
a between-groups difference in IL-6 in the absence of the ESR group’s sleep restriction
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manipulation. In other words, IL-6 is elevated amongst the group deemed naturally sleep
restricted and not in the group exhibiting normal sleep. Interestingly, IL-6 was not
elevated following the sleep restriction week for the ESR group, and this may be
accounted for by Shearer and colleagues’ (2001) finding that IL-6 elevations only began
emerging following four days of sleep restriction. Although participants underwent
seven days of sleep restriction, it is possible that the length of our sleep manipulation was
not long enough in order to identify significant differences within and between-groups.
Despite the elevated IL-6 in the NSR group, this group did not exhibit greater
dysfunction across the psychological variables. Although IL-6 was elevated in the
absence of psychological dysfunction, this was not the case for IL-1β, which was
elevated along with concomitant decrements in psychological health.
While not directly related to our original research questions, there is an increasing
amount of research examining the link between inflammation and psychological health.
For instance, exposure to psychological stress is associated with elevations in proinflammatory cytokines (Johnson et al., 2005) and IL-6 in particular has been implicated
in depression (Henry et al., 2008). Irwin (2015) further specifies that elevations in IL-6
predict depression, noting that inflammatory markers are reliably more elevated among
depressed versus non-depressed individuals. This runs contrary to our findings, which
demonstrate elevated IL-6 in the absence of depressive symptomatology. Of course,
selection bias may have impacted these findings, given that participants with existing
psychopathology were excluded from the current study. It is intriguing however, that IL-6
did not increase over the sleep restriction week, yet depressive symptomatology
decreased. These findings raise the possibility of whether non-clinical samples’
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inflammatory markers act differently in the face of sleep restriction. For instance, does
the volitional component of the NSR group’s reduced sleep make it less likely for them to
experience depression compared to a group of depressed individuals whereby impacted
sleep is a characteristic feature of depressive disorders? Similar to IL-6, IL-1β has also
been implicated in depression, with elevations in IL-1β accompanying depressive-like
behaviors (Liu, Wang, & Jiang, 2017). Again, the current study’s results did not support
an increase in depression, but rather, a rise in IL-1β was accompanied by a decrease in
depression, and the fact that our study was comprised of a non-clinical sample likely
impacted these findings.
Out of the various indicators of psychological health, depression has received the
most attention as it pertains to its relationship to inflammation. Other indicators have
received attention but have primarily been in the context of specific diagnoses. For
instance, markers of inflammation have been tied to bipolar disorder (Koo & Duman,
2008), posttraumatic stress disorder (Maes et al., 1999), as well as anxiety disorders (Hou
& Baldwin, 2012). While meaningful in strengthening the link between inflammation and
psychological health, it is unlikely that the mechanisms explicating this relationship can
be extrapolated to the current study, given the confounding factor of a psychological
disorder that is central to many of these studies. According to de Wild-Hartmann and
colleagues’ (2013) findings, poor sleep predicts decrements in psychological functioning,
whereas the reverse does not hold true. Importantly, the same cannot be said for
individuals with pre-existing psychiatric diagnoses, who frequently exhibit comorbid
sleep disorders secondary to their diagnosis. Even though there is some research linking
various markers of inflammation to specific changes in psychological functioning among

102
non-clinical samples (i.e., Pitsavos, Panagiotakos, Papageotgiou, Tsetsekou, Soldatos, &
Stefanadis, 2006), the roadblock that we encounter in extrapolating these results to the
current study’s entails the large number of variables at play, all having the potential to
confound our results. These include the specific type and length of sleep restriction,
gender, endogenous hormonal fluctuations, specific variables measured (i.e., biological,
psychological), and inclusionary/exclusionary criteria across studies. Thus, in light of
these factors, our understanding of biological and psychological functioning especially
among non-clinical samples is not well understood.
Taken together, there is mounting evidence to suggest a relationship between
sleep loss, inflammation, and psychological health, yet our understanding of the isolated
effects for specific populations following certain manipulations is not well understood.
Despite this, the current study suggests that IL-1β and IL-6 respond differently to sleep
restriction that is either volitional or non-volitional amongst a sample of young females.
Further, we identified that IL-1β and not IL-6 rises along with anxiety, tension, and
fatigue, and that the rise in IL-1β is also accompanied by a decrease in depression and
anger. Finally, it may be that IL-6 was not accompanied by concomitant self-reported
decrements in psychological functioning as a result of factors pertaining to volition and
habituation. If so, these results are a further indication that sleep restriction itself
constitutes a stressor, especially under circumstance where it is non-volitionally imposed.
Importantly, we cannot ascertain that the changes in psychological functioning drive the
changes in biological functioning, or vice versa. Rather, it appears as though both are
vulnerable to the effects of sleep loss, and further research that attempts to elucidate the
specific effects and possible interactions is needed.
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With respect to the neurocognitive findings, we did not find any significant
results, but did find large effect sizes – although only one was in line with our
hypotheses. In terms of the intragroup comparisons, we found that following sleep
restriction, the ESR group’s reaction time declined on the NBACK, which stands in
contrast with the literature (Waters & Bucks, 2011). With respect to the intergroup
findings, large effect sizes indicating increased reaction time for the NSR group
compared to the ESR group at Day 7 on the LOT and NBACK were found. Again, these
results did not support our hypotheses. Finally, the one large effect size supporting our
original hypotheses entailed a greater number of correct matches on the NBACK for the
ESR group at Day 1 relative to the NSR group. While this finding indicates reduced
performance on the NBACK among the naturally sleep restricted group, it is suspect that
this is the only finding out of the intragroup and intergroup comparisons that aligned with
our hypotheses, given that the literature linking sleep restriction to reduced
neurocognitive functioning is relatively robust. We believe that matters related to reduced
motivation on the participants’ part to perform optimally and understand the task may
help to explain why the majority of the large effect sizes run counter to our hypotheses
and the literature.
Viewed in conjunction with the biological and psychological variables, we did not
see any indication across the neurocognitive measures of impaired inhibition following
sleep restriction. Thus, the decline in depression and anger that was observed following
sleep restriction in the ESR group may have been present as the participants’ inhibition
was not impacted. In other words, increased anger may be the result of reduced
inhibition, and given that we did not observe reduced inhibition, perhaps explains why
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anger did not increase. Rather, we are more inclined to attribute the decline in anger to a
muting of their emotional response as a result of fatigue (Hatfield et al., 2002), aligning
well with Cohen-Zion and colleagues’ (2016) finding that attributes reduced motivation
to sleep restriction. Given our lack of confidence in the neurocognitive findings we are
hesitant to over-interpret what we have (and have not) found in conjunction with the
biological and psychological measures.
Limitations and Future Research
As indicated, the current study examined whether sleep restriction altered one’s
mean levels of cortisol, IL-6, and IL-1β. While an important exploration, we did not
examine the biomarkers’ secretory patterns, which would have required the repeated and
consistent sampling of saliva samples on a daily basis. As a result, our ability to infer
whether naturally or experimentally sleep restricted participants experienced alterations
in their biomarkers’ diurnal rhythms cannot be ascertained. It is possible that our
observed lack of difference in cortisol within the ESR group can be accounted by the
length of the sleep manipulation; more specifically, increases in cortisol following sleep
restriction have been documented following 10 nights (e.g., Banks & Dinges, 2007) as
well as eight nights (e.g., Vgontzas et al., 2004). Further, Tartar et al. (2015)
demonstrated that sleep restriction is associated with elevations in mean cortisol levels,
however only when accounting for a later time to bed – a variable not accounted for in
the current study. Thus, additional research examining various length of sleep restriction
in addition to participants’ time to bed would further our understanding.
An additional limitation regarding the biological variables relates to the small
sample size; in particular, our significant finding of an increase in IL-1β following a
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week of sleep restriction is based on a sample size of four. While this result was
accompanied by a very large effect size, the extant literature regarding the interplay of
IL-1β and sleep remains misunderstood and understudied. Finally, it may be that IL-6 in
the ESR group did not significantly increase in response to sleep restriction due to the
constricted time period, as has been noted in the literature (i.e., Shearer et al., 2001).
Taken together, additional research should attempt to examine whether cytokines’
patterns of secretion change in response to sleep manipulations, as well as identifying
how long sleep restriction must occur for prior to identifying elevations in IL-6. In doing
so, this would inform the timing and number of samples needed to detect alterations.
Finally, and in light of the small sample size seen particularly in our examination of IL1β, we encourage that additional research be conducted as to attempt a replication of our
findings.
With respect to the psychological variables, as indicated a possible limitation
pertaining to the instruments’ criterion validity is suspected. Given our findings that
denote increased fatigue in the absence of sleepiness, and increased anxiety and tension
in the absence of stress, we question whether these measures adequately captured the
participants’ psychological status. As such, psychometric research attempting to verify
matters related to criterion, convergent, and discriminant validity is warranted. An
additional limitation relates to demand characteristics participants may have experienced,
particularly amongst those in the ESR group. Given that the ESR participants met with
the experimenters across several sessions, relative to the NSR participants who only met
with the experimenters on one occasion, we raise the possibility that the increased
exposure inadvertently led the participants to answer questions in a biased fashion as to
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confirm suspected hypotheses. Finally, in synthesizing our interpretation of the biological
and psychological variables, our exclusion of participants having pre-existing and/or
current psychopathologies negated our ability to identify whether elevations among
specific cytokines related to elevations among specific indicators of psychological health.
While the current study found an increase in IL-1β along with an increase in anxiety,
tension, and fatigue along with a decrease in depression and anger, these results stand in
contrast with existing research suggesting a positive correlation between IL-1β and
depression. Therefore, is this accounted for by the current study’s non-clinical status? Or
rather, does the nature of the sleep restriction lead to elevations of IL-1β under certain
circumstances and IL-6 under others? Thus, further elucidating and teasing apart the
mechanism driving the effect is warranted.
In terms of the neurocognitive variables, this class of variable resulted in
significant limitations. Primarily, there is very little research on the Joggle Research
platform that detail its psychometric properties, with respect to both internal and external
validity. Despite the lack of available psychometric research, the discrete subtests
embedded within it are generally regarded as exhibiting strong psychometric properties.
Although consisting of well-researched subtests, we question whether the program and
platform itself exhibited adequate external validity in capturing the participants’
neurocognitive functioning in both the NSR and ESR groups. From the viewpoint of
existing literature, we would have expected that some findings align with welldocumented trends, such as an increase in reaction time. Rather than find this effect, the
opposite effect emerged, further calling into question the instrument’s validity. From an
observational standpoint, it was noted that relative to the psychological measures,
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participants exhibited a greater tendency to request clarification for the task at hand.
Although this did not uniformly happen, it may be that participants had difficulty
comprehending some of the subtests. Taken together, these limitations severely hinder
our ability to have confidence in our interpretations, particularly in gauging whether we
were actually detecting the intended constructs,.
In all, if future research includes the Joggle Research platform, we recommend
that additional and convergent measures also be included, as a means for expanding our
understanding of its psychometric properties, while also serving as an opportunity to
establish convergence and/or discriminant validity between the measures. As indicated,
its discrete subtests generally show sound psychometric properties, yet the platform itself
currently lacks adequate psychometric research.
Final Comments
In all, the current study yielded several large effect sizes and a relatively smaller
number of significant effects, which resulted from the small sample size and conservative
corrections implemented to control for familywise error rates. Despite this, the small
sample size was sufficient in detecting large effect sizes across all three classes of
variables. Although some of our hypotheses were not supported, several of the current
study’s findings add to the literature in providing a comparison of the effects of volitional
and non-volitional sleep restriction among a female sample. Because we grouped our
participants on the basis of whether they were naturally sleep restricted or experimentally
sleep restricted, we were able to gauge how different forms of sleep restriction
differentially impacted these participants, thereby contributing to the extant literature’s
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ecological validity, which has primarily examined sleep deprivation manipulations while
also excluding females.
Given that some of the current study’s large effect sizes run counter to what has
been described in the literature, and that our study did include a small sample size, we
believe that significantly more research is needed in order for us to elucidate our
understanding of the link between sleep restriction and its various consequences. We
acknowledge that developing a cohesive picture is muddled by the sheer number of
confounding variables, yet also believe that this is a worthwhile endeavor. Evidently,
sleep loss is pernicious to one’s health, but the interindividual differences in how
biological, psychological, and neurocognitive functioning are impacted has yet to be
entirely understood. We believe that advances within the field of
psychoneuroimmunology will necessitate a greater appreciation for the ties between
biological and psychological functioning, as well as what these specific interindividual
differences entail. As a means for doing so, the current study examined the biological,
psychological, and neurocognitive consequences of sleep restriction among a sample of
young women who were either naturally or experimentally sleep restricted.
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Appendix A
Group Comparisons on Screening Measures
Total Minutes Slept
Group
NSR
ESR

n
11
9

M
392
445

SD
25
36

PSQI
M
5.18
3.44

ISI
SD
1.33
2.46

M
8.55
3.38

SD
4.25
1.5
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Appendix B
Group Comparisons on Demographic Variables
Age

BMI

Group

n

M

SD

M

SD

Caucasian

Race (n)
African American

NSR
ESR

11
9

19.64
19.67

1.03
1.41

25.00
24.49

7.59
5.38

5
5

3
0

Hispanic Asian
2
1

1
3

